ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001409.1|Dutomycin_1 # 2 # 1519 # -1 # ID=1_1;partial=10;start_type=ATG;rbs_motif=GAG;rbs_spacer=5bp;gc_cont=0.735	BGC0001409.1|Dutomycin_1 	2	1519	-	Loose	550	339.732	Nocardia farcinica rox	45.05	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGAACACCGACGTCGTCGTGGTGGGAGGCGGTCCGGTCGGCCTGTTGCTCGCCGCCGAACTGCGCCTCGGGGGTGCCCGCGTGGTCCTCCTGGAGCGGCTGACCGAGCCGAGCGGCCACTCCAGGGCCTTCCGCATGCAGGCCAGGATGCTGGACGTACTGGACCAGCGGGGCCTGCTCGGCCGGTTCATGGAAGGCAACCGCACCTGGCCCAAGGCCCACTTCGCCGGCCTGGAACCGCTGCTCGACTTCGGACACCTGCACAACGAGCATCCGTACGCCCTGCTGATCCCGCAGGCGCGCACCGAGGAACTGCTGGAGGAGTACGCCCTGTCGTGCGGGGTGGAGATCCGTCGCGGACACGCGCTGACCGGGCTCGACGCCACCCCCTCCGACGTCGTGGCCGAGGTCGACTCGCCCGAGGGAACGTACCGGTTGCGCTCGCACTACCTGGTCGGCTGCGACGGCGGGCGCAGCACCGTCCGCAAGCTCGCCGGCATCGGCTTCAGCGGCTCGGCGCCCACGGTGCGCGCGCTCCTGGCCGACGTGGAGCTCGCCGATCCCGGACAGCTGCCCAACGGAGTGCCGGGCACCATGCGCACCCCGCGCGGCCTGCTGATGGCGATCTCGCTGCAGCCCGGGGTGACCCGCGTGCTCACCACGGAGTTCACCCCGCCGGAGCCGGGTTCCGAGCACACCCCGGTGACCCTGGACGAGCTGCGCGAGACGGTACGGCGGATCACCGGCATCGGCGTCGCCATGGACCGGCCGCGCTGGCTGTCCCGGTTCGCCGACACGACCCGGCTGGCCGACACCTACCGGCAGGGCCGGGTGCTGCTCGCCGGTGACGCGGCGCATGTGCACTTCCCCATCGGGGCGCAAGGACTCAACCTCGGCCTGCAGGACGCCGTCAACCTGGGCTGGAAGCTGGCCGGGACGATCGTCGGCTGGGCTCCCCCCGGGCTGCTCGACAGCTACGGCTCCGAACGCCGCCCGGTCGCCGAGCGCGTGCTGCGCGAGACCCGGGTGCAGCTGATGCTCATGGCCCCCGACCCCAAGGTCGACCCGCTGCGCGAGATGTTCTCGGAACTCCTCGCGCTGCCCGAGGTCAACAGCAGGCTGGCACACGAGATGACGGGCCTCGACGTCCGCTACACCCCGGCTCCGGGCCGCTACGAGCACGAACTGCTCGGCCGCCCCTGCCCGCCGCTCGCGGAAGCGGTCGGTGACGAGGTCCGCAGGGTGCTGCGCACGGGACGCGGAGTGCTGCTCCTGCCGGAGGGCCCGGCTCAGGAGGCGGCCGGGCTCGCCGCCGACTGGTCGCACCGCGTCGGCATGGTCCCGGCCGAGGGCGGAGCGGGCCTGCTGCTGCGCCCGGACGGCCATGTGGCGTGGGCGGACCCCGGCGACGGCGTACCGCGCAAGGACGCGCTGCTGGAGCTGGAGGACGCCCTGCGGCACTGGTTCGGCGCCCCGGGCTGCACGGTCGTGCCCCGGACCCACCACGACGCGACGGGC	MNTDVVVVGGGPVGLLLAAELRLGGARVVLLERLTEPSGHSRAFRMQARMLDVLDQRGLLGRFMEGNRTWPKAHFAGLEPLLDFGHLHNEHPYALLIPQARTEELLEEYALSCGVEIRRGHALTGLDATPSDVVAEVDSPEGTYRLRSHYLVGCDGGRSTVRKLAGIGFSGSAPTVRALLADVELADPGQLPNGVPGTMRTPRGLLMAISLQPGVTRVLTTEFTPPEPGSEHTPVTLDELRETVRRITGIGVAMDRPRWLSRFADTTRLADTYRQGRVLLAGDAAHVHFPIGAQGLNLGLQDAVNLGWKLAGTIVGWAPPGLLDSYGSERRPVAERVLRETRVQLMLMAPDPKVDPLREMFSELLALPEVNSRLAHEMTGLDVRYTPAPGRYEHELLGRPCPPLAEAVGDEVRRVLRTGRGVLLLPEGPAQEAAGLAADWSHRVGMVPAEGGAGLLLRPDGHVAWADPGDGVPRKDALLELEDALRHWFGAPGCTVVPRTHHDATG	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	106.98	gnl|BL_ORD_ID|4834|hsp_num:0	5821			6	1413	rifampin
BGC0001409.1|Dutomycin_2 # 1860 # 3488 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=6bp;gc_cont=0.729	BGC0001409.1|Dutomycin_2 	1860	3488	+	Loose	600	180.644	Streptomyces venezuelae rox	36.52	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGGCAGTGACGAAAGGAACCCGCACCCCCCAGGTACTCGTGGCGGGGGCCGGCCCGGTGGGGCTCGCCCTGGCCTACGAACTCGCCCGCCGTGGAATCCCGTTGCGTCTCATCGACGCCAAGGACGCGCCCGCGACCACCAGTCGCGCCGTCGCCACGCATCCGCGCACGCTGGAGGCGTACGACCAGATGGGTCTGGTCGAGGAGATGCTCAAGCGGGGCCGGGAGATCCGGGCCTTCACCCTCTTCCAGGACGGCCGTCGGCTCGCCCGCCTCGATGCGGACTACTCGACCATGCCGACCCGCTTCCCGTTCACGCTGGCCATCGAACAGACGGCGACCGAGGAGGTGTTCCGCGACGCTCTCGCGGATCTCGGCGTGGTCCCGGAGTGGGGCACGAGCCTGGAGCGGATCGCGCCCGACGACGACGGGGTGACCGTCGGGCTGAGCCATACCGACGGCCGCGACGAGACGGTCCGCGTCCCGTGGCTGGTCGGCTGCGACGGCGGCCACAGCACCGTACGCCGCTCCCTCGAACTCCCGCTGATCGGCGAGGCGAACCAGACCTGGCTGCTGGCCGACGCGCCCATGACGAGCGAGCTGCCGCCCAACAGCATCTACTGGGTGCGCACCGACGGCGGCACGCTGATGGCGGTGCCCCTCGCCGACGACCGATGGCGACTGCTGGACACCGCCGAGACCGACTACGACGGCGACCCCGACCGTCTCGCGGCGCGCTTCGAGCGCAAGCTCAGCCAGGGCCTCGGCCACCAGGTGCGCATCGGCACACCCACCTGGGTGTCGGTCTTCACGGCCCAGCAGCGCATGGTCCCGAACATGCGGGTCGGCCGCTGTCTGGTCGCGGGCGACGCCGCCCATGTGCACAGCCCGGCCTCCGGTCAGGGCATGAACACGGGCATCCAGGAAGCCGTCAACCTCGCCTGGAAGCTGGCCATGGTCGTCGAGGGACATGCTCGCGCGGAGCTGCTCGACAGCTACACGAGCGAGCGCGTGCCGGTGGGTGAGGCGCTCCTGGAGTCCACCAAGAAGGCCACCCAGATGATCGAGCTGCGCAGCCGGTTCACGGACCTCGCGCTGCCCGTGATCTTCGGCGTGGTGAGCCGGGTCGCCCCGATCCGCAAGCGGATGCAGCGGGAGATGCTCGGCGGGATGTCCGGCCTGCTGCTCTCGTACGCGGATCGCACCCTCACCGCCCCGGACGGCCACGGCGGCAGCGGCCCCCGTCCGGGCGCCCGGCTCACCGAGGTCACCGACTCCGATCTCACGGGCACCGGCTGGCCCGCGCTGCTCGCGGCGCTGCGCCGGCCCGGCTGGCTGCTGCTGGCGGCCGCCTCGCCCGGCGACCCCGCCGTAGCGGAGACGGTCCGCCGGGCGCGCGCCGAGTACGGGCCCTGGCTGTCGGTGCTGAGCGTCACCGAGGCGAAGTCGGCCACGGACCCGGAGGTGATCCCCGACGGCGACGGGCGGGTGTCCGACCGGCTCGGTCTGTCTCCCGGCGGATGGCTCCTGGTCCGCCCCGACGCCTATCTGCTCGCCCGCGGGCCCGCCCTGTCGCCGGCCGCACTGTCCGACGCGCTCGGCCGGCTGCCGCTCGCCCGTCCCGTCTGA	MAVTKGTRTPQVLVAGAGPVGLALAYELARRGIPLRLIDAKDAPATTSRAVATHPRTLEAYDQMGLVEEMLKRGREIRAFTLFQDGRRLARLDADYSTMPTRFPFTLAIEQTATEEVFRDALADLGVVPEWGTSLERIAPDDDGVTVGLSHTDGRDETVRVPWLVGCDGGHSTVRRSLELPLIGEANQTWLLADAPMTSELPPNSIYWVRTDGGTLMAVPLADDRWRLLDTAETDYDGDPDRLAARFERKLSQGLGHQVRIGTPTWVSVFTAQQRMVPNMRVGRCLVAGDAAHVHSPASGQGMNTGIQEAVNLAWKLAMVVEGHARAELLDSYTSERVPVGEALLESTKKATQMIELRSRFTDLALPVIFGVVSRVAPIRKRMQREMLGGMSGLLLSYADRTLTAPDGHGGSGPRPGARLTEVTDSDLTGTGWPALLAALRRPGWLLLAAASPGDPAVAETVRRARAEYGPWLSVLSVTEAKSATDPEVIPDGDGRVSDRLGLSPGGWLLVRPDAYLLARGPALSPAALSDALGRLPLARPV	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	113.87	gnl|BL_ORD_ID|4833|hsp_num:0	5820			9	1026	rifampin; rifaximin; rifapentine
BGC0001409.1|Dutomycin_3 # 3498 # 4253 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=8bp;gc_cont=0.738	BGC0001409.1|Dutomycin_3 	3498	4253	+	Loose	450	46.2098	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	25.0	3004045	protein variant model	G93V	n/a	disinfecting agents and antiseptics; isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant fabI	ATGGATCTCGGACTGACCGACCGGGTCGCCCTGGTCACCGGGGGCACCCGGGGCATCGGCGAGGCCACCGTGCGCGCCTTCGCCGCCGAAGGCGCCCGCGTCGCGCTGACGTACGCCGGCTCGAAGGACAGGGCGGCCGATCTGGTCGGCGAACTCGGCGGCCCGGAGCGGGCCCTGGCCGTCCACTACGACCTGGCCGACCCCAGTTCGGTGGAGGACCTGGTGCCGGCCGTCGAGCGGCACTTCGGCGCGGTGGACGTGCTCGTCGCCAACGCCGTGCGGCGGCCCGCGGGACGCCCCGCCCCGGGCTTCGAACATCTCGACCCGGCGTCCTGGACCGCGTACCTCGACGACAACCTGACGGCGACGATCCGCACCGTGCAGACCGCGCTCGCCGGGATGCGCGCACGCGGCCACGGCCGGATCGCGCTGATCTCCTCCCACTTGGCGGCCAAAGGGCAGGCGGGGCAGGAGGTCTACACGGCGGCCAAGTCGGCGCTGCACGGCTTCGCGCTCAGTCTGGCCCGCGACGCCGGACCCGACGGCGTCCTGGTCAATGTGGTCAGCCCGGGGCTCACCACGACCGAGGGCGCTCTCCAGCACTTTCCCGCAGCCGTCCTGGAGAAGGCGGCCGCCGCGCTGCCGACCGGGCGCCTCGGCAGCCCGGAGGAGGTCGCCAGGACTGTCGTCTTCTACTGCTCGGCGGCCAACGAGAACATCACCGGCGAGCTGGTCTCCCTGGTCGGGCGCGGGTGA	MDLGLTDRVALVTGGTRGIGEATVRAFAAEGARVALTYAGSKDRAADLVGELGGPERALAVHYDLADPSSVEDLVPAVERHFGAVDVLVANAVRRPAGRPAPGFEHLDPASWTAYLDDNLTATIRTVQTALAGMRARGHGRIALISSHLAAKGQAGQEVYTAAKSALHGFALSLARDAGPDGVLVNVVSPGLTTTEGALQHFPAAVLEKAAAALPTGRLGSPEEVARTVVFYCSAANENITGELVSLVGRG	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	95.80	gnl|BL_ORD_ID|4712|hsp_num:0	2666			9	747	triclosan
BGC0001409.1|Dutomycin_4 # 4318 # 5247 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.694	BGC0001409.1|Dutomycin_4 	4318	5247	+	Loose	900	27.7202	PmpM	24.21	3004077	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; aminoglycoside antibiotic; disinfecting agents and antiseptics	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	GTGGTCAACACCCAAGCCCCCGTGGGCGAATCGGTCGTCGTCGAGGCCCCGGCGAAGGTCGTCCTCGACCTGATCGCCGACCCCGATCCGCTGCACTACCTCTCCCCCACCATCGTCTACGCCGACCGGGTCACCGTCGGCCCGGCCCAGGACCGGGTGACGGTGTGGACGATCACCGGGACCGAGCAGGTGTGGTCGCGCACCCAGCACCGCACCCTCGACCCCGACGGCCTGCGGGTCACCTTCGAGGACACGCCCGAGTCCACGCTCGCCGGAGTGCGGGGCGAGTGGCTGCTGCGCGCGGTGTCGGACGACAAGACCGAGATCGAGCTGAAGCAGGACACGAGTGCGCTCACCTCCCCCGAGGCCGTCACCCGGGCCGAGGAGGCGCGGTCCGACCTGCTGTCCACGGTGGCGTACGCCGCCGCGAACCGGCAGGAACTGTCCGACCTGGTCGTCGACTTCCGTGACCCGCTCTTCGCCGCGGGGTCCGCCGAGGACGCGTACAAGATCCTCAACGAGGCCGATCGCTGGCCGGAGCGGCTCTCGCATGTCTCCCGGATCGACATGACCGAGGAGGTGCCGGGCATTCAGTTCTTCGACATGGACACCACGACGTCCGACGGCGCCCCGCACACGACCCGTTCGGTGCGGATCTGCTTCCCTCACTCGAAGATCGTCTACAAGCAGATCGGGCTGCCCGCGCTGCTGGCCGCGCACACCGGGCACTGGCTGTTCACCCCGACCCGCGAGGGGATCGTCATCGAGTCCCGGCATGTCGCCGTCATCAAGCCGACGGCGCTGTCGATCCTCGGCGAGGGCACCACGGTCGAGGACGCCCGCCGCTATCTGCGCCGGGTGCTGAGCACCAACTCCATGACCAATCTGCGGCTGTCCAAGGAGTTCGCGGAGGAGCAGGCGCGTGCGTGA	MVNTQAPVGESVVVEAPAKVVLDLIADPDPLHYLSPTIVYADRVTVGPAQDRVTVWTITGTEQVWSRTQHRTLDPDGLRVTFEDTPESTLAGVRGEWLLRAVSDDKTEIELKQDTSALTSPEAVTRAEEARSDLLSTVAYAAANRQELSDLVVDFRDPLFAAGSAEDAYKILNEADRWPERLSHVSRIDMTEEVPGIQFFDMDTTTSDGAPHTTRSVRICFPHSKIVYKQIGLPALLAAHTGHWLFTPTREGIVIESRHVAVIKPTALSILGEGTTVEDARRYLRRVLSTNSMTNLRLSKEFAEEQARA	MNSPALPLSRGLRIRAELKELLTLAAPIMIAQLATTAMGFVDAVMAGRASPHDLAAVALGNSIWIPMFLLMTGTLLATTAKVAQRHGAGDQPGTGPLVRQALWLALLIGPLSGAVLWWLSEPILGLMKVRPELIGPSLLYLKGIALGFPAAALYHVLRCYTNGLGRTRPSMVLGIGGLLLNIPINYALIYGHFGMPKMGGPGCGWATGSVMWFMFLGMLFWVNKASIYRASQLFSRWEWPDRATIGPLVAVGLPIGIAVFAESSIFSVIALLIGGLDENVVAGHQIALNFSALVFMIPYSLGMAVTVRVGHNLGAGLPRDARFAAGVGMAAALGYACVSASLMLLLREQIAAMYSPDPAVIAIAASLIVFSALFQFSDALQVTAAGALRGYQDTRVTMIMTLFAYWGIGLPVGYSLGLTDWFQEPTGPRGLWQGLVVGLTGAAIMLCIRLARSARRFIRQHERLQREDAEAASVLGR	64.78	gnl|BL_ORD_ID|2378|hsp_num:0	2734			1119	1380	neomycin; benzalkonium chloride; chlorhexidine
BGC0001409.1|Dutomycin_5 # 5240 # 6727 # 1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.722	BGC0001409.1|Dutomycin_5 	5240	6727	+	Loose	1000	44.2838	almE	25.98	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGCGTGAGCCCGTCGAGCGCCTGGACGACCTGCCGCGGCGCGCCGCCGAGGCCGACCCGGACGGTGTGGCCGTCCGCACGGACCGCGGCGACGCGCTGACCTTCGGCGAGCTGGAACGGCGGGTGAGCGGCTGCGCGGCGCGGATCCGGAGCCTGGCGGGCGGACCCGGCGTGGTCGTCGCGATCACCTCCGTCCTCCATCCCGACTTCGCCGTGGCGTACTTCGGGACGCTGCGCGCGGGCAATGTCGTCGTGCCGGTCAACCCGTTCCTGCGCGCGAAGGGGCTGGAGGCGCTCGTCGCCGCGAGCGGGGCCCGGCTGGTGCTCACCACCCAGGAGATCGCCGGCCAGCTCGGCGGCGGGGTGCCCTCGCTGGACATCGGCGACCGGGCGCTGTGGGACACCGAGCCGCTCGTGGACGTGCCCGCCGTCGGTCCCGACGACATCGCGTCCGTGCACTTCACCAGCGGTACGACCGGCGATCCCAAGGGCGTGCGGCAGACACACCGCAACCTGGCCGTCAACGCGGCACAGACCGTGCACGCCCACGGCCTCGACAGCACCTCGGTGACGGTCAACCACCTGCCCACCTACCATCCGATGCATCTCAACTCGGCACTGTTCGCGGGTGCCGAGCAGGTGCTGGCCACCGATCCGGACCTGGCCGCGTCGCTGCGGACGGCGAACGAGGCACGGGCCACCCGGTACTACAGCCTGCCGATGCGGCTCAGCCGGCTCGCCGTGCGTCCGGACCTCGCGAAGCTGCGCCTGGAGACCGTTCAGGCCATCTTCTCCGGCGGCTCCGCGCTGCCGGTGCCGGCGGCGCGGACACTCGGCGACCACTTCGGAATCCCGGTCCTACAGGGGTACGGGCTCGCCGAGACCGCGCCGATGACCCATTGCGGCAGCCGCACCCACCCGAAGGACGGTTCCTGCGGGCCGCCGGTCCCGCTCACCGAGTGCCGGATCGTGGATCTCACCACGGGCAAGGCCCTCGGCCCCGGCGAGCGGGGCGAGATCCAGGTGCGCGGCCCTCAGCTCATGAAGGGGTACCTGGGTGAGCCCGACGGGGCGGCCGTGGACGCCGAGGGCTGGTTCGCCACGGGCGACGTCGGCCAGGTCGACGAGGACGGCTACCTGTTCGTCGTCGACCGGCTCAAGGACGTCTTCAAGTGCGACAACTGGCTGGTCTCCCCCCAGGAGATCGAGCAGGTGCTGCTCGCACATCCCGCCATCGCGGACGGTGTGGTCGTCGACCACCCGGACGAGTTCAGCGGTGCCGTCGCGGTCGCCCTCGTGGTGACCCGTCGCCCCGAGGAGCGGGAGGCCCTCGACGCGATCGCCGCGGACGTCAACTCCGGTCTGCCGTACTACCAGCACATCCGGCACATCCGGGCGGTCCCGGAAATCGCCCGGTCCGGCGGGGGAAAGGTACGCCGCCAGGATCTGCGCCGGCTCTTCGAGGATCTGCTCGTCACAAGCGACTGA	MREPVERLDDLPRRAAEADPDGVAVRTDRGDALTFGELERRVSGCAARIRSLAGGPGVVVAITSVLHPDFAVAYFGTLRAGNVVVPVNPFLRAKGLEALVAASGARLVLTTQEIAGQLGGGVPSLDIGDRALWDTEPLVDVPAVGPDDIASVHFTSGTTGDPKGVRQTHRNLAVNAAQTVHAHGLDSTSVTVNHLPTYHPMHLNSALFAGAEQVLATDPDLAASLRTANEARATRYYSLPMRLSRLAVRPDLAKLRLETVQAIFSGGSALPVPAARTLGDHFGIPVLQGYGLAETAPMTHCGSRTHPKDGSCGPPVPLTECRIVDLTTGKALGPGERGEIQVRGPQLMKGYLGEPDGAAVDAEGWFATGDVGQVDEDGYLFVVDRLKDVFKCDNWLVSPQEIEQVLLAHPAIADGVVVDHPDEFSGAVAVALVVTRRPEEREALDAIAADVNSGLPYYQHIRHIRAVPEIARSGGGKVRRQDLRRLFEDLLVTSD	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	89.03	gnl|BL_ORD_ID|4935|hsp_num:0	5928			582	1401	colistin A; colistin B
BGC0001409.1|Dutomycin_6 # 6765 # 7052 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=7bp;gc_cont=0.660	BGC0001409.1|Dutomycin_6 	6765	7052	+	Loose	250	24.2534	FosC2	42.86	3002874	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosC phosphotransferase family	ATGGTGACCCTGATCAACAAGTTCACGGTGACGGGCGAGATCGACACGTTCCGGCGCGCCATCGCCGAGGTCAGCGCCTATATGCAGGCGCAGCCGGGCTTCATCAGCCACGAGGTGTACCGCTCGATCAACAACCCGAACATCTTCGTGGAGACCGCCCACTGGGACGACCCCGACTCGCACAAGAAGGCCGTGCAGAGTGACGAGTTCCGCAGCCGCGTACGCGGCCTGGCCGGGCTCGCCACGCCGGACGCCGACCTGTACACCCCGGTCGGCGACGACCACTGA	MVTLINKFTVTGEIDTFRRAIAEVSAYMQAQPGFISHEVYRSINNPNIFVETAHWDDPDSHKKAVQSDEFRSRVRGLAGLATPDADLYTPVGDDH	MLRGLNHITIAVSDLERSVEFYTRLLGMKAHVRWDSGAYLSLEATWICLSCDEVHPSQDYCHIAFDVSEENFEPVTKKLREAHVVEWKQNRSEGLSLYLLDPDGHKLEIHSGSLQSRLESLKSKPYQGLVWL	71.97	gnl|BL_ORD_ID|1897|hsp_num:0	2060			300	363	fosfomycin
BGC0001409.1|Dutomycin_8 # 7672 # 8724 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.698	BGC0001409.1|Dutomycin_8 	7672	8724	-	Loose	400	30.0314	ErmG	18.4	3000522	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACCCAAGAAACCCAGGCGGCGTACTCCTTCGTCGACCGGCCGGACGTTTCGCTGCGCCAGCGGCTGATGCTCCTCGCCAACGGTCAGCGGTTCTCCGCGGTCGTGTACGCGCTGGCCGAACTCAATGTCGCCGACCAGCTGATCAAGGGCCCGCGCACGGTCACCGAACTCGCCGACGCCGTCGGTGCCGACGAGGCCGCGCTCTACCGGATGCTGCGCTGTGCCGCGCTGCTCGGCGTGTTCCAGGAGCTCGACGGGCGGCAGTTCGCCCTCACCCCGATCGCCGAGGGGCTGCGTACCGACCTGCCCGACGGGGTGCGGGACGCCGTGCTGCTCGACGGATCCGGCTTCTTCTGGGGTTCGTTCGGCTCGATCCTGCACTCCGCGCGGACAGGCCATCCCGGCTTCGACGCGGCGAACGGCATGTCCTTCTGGGAGTATCTCCAGGCCAACCCGGAGGCCGGCGAGGTCTTCGACGACGCCATGACCACCATCAGCCGTCGGCTCGGCGGGCTCTACCTGGATCGCGTCGACTTCTCGCGGTTCCCCGTCCTGGCCGACGTCGGCGGCGGCCGCGGTTACTTCCTCGCCGAGATCCTCCGCCGCAACCCCGGCATCCGCGGTGTCCTGTTCGACCGCCCCCAAGTCACGGACACCGCCGGGGAGTTGCTCGGCGAACGGGAGGTGGCCGAGCGGGTCGACGTGGTCGGCGGCGACTTCTTCACCGATCCGATCCCGGCCGGCTGCGACGCGTACGTCCTGAAGACCGTGCTGCACGACTGGCCGGACGAGAAGGCCGTACAGATCCTGCGCCGGGTACGCGAGGCGATCGGCGACTCCGCGGGGCGGCTGCTCGTCCTCGAACAGGTCGTGGCACCCGGCAACACCTGGGACACCGCCAAGTTCCTGGACGTGGACATGCTGGTGGTGATGGGCGGCCGCGAGCGCAATCTCGACGAATGGCGCGAGCTGTTCGCCGCCGGCGGATTCGAGCTGGACTGCGAGCCGGCCGTCGGCGACTGGGCGGTCCTGGAGTGCAAGCCCCGCTGA	MTQETQAAYSFVDRPDVSLRQRLMLLANGQRFSAVVYALAELNVADQLIKGPRTVTELADAVGADEAALYRMLRCAALLGVFQELDGRQFALTPIAEGLRTDLPDGVRDAVLLDGSGFFWGSFGSILHSARTGHPGFDAANGMSFWEYLQANPEAGEVFDDAMTTISRRLGGLYLDRVDFSRFPVLADVGGGRGYFLAEILRRNPGIRGVLFDRPQVTDTAGELLGEREVAERVDVVGGDFFTDPIPAGCDAYVLKTVLHDWPDEKAVQILRRVREAIGDSAGRLLVLEQVVAPGNTWDTAKFLDVDMLVVMGGRERNLDEWRELFAAGGFELDCEPAVGDWAVLECKPR	MNKVNIKDSQNFITSKYHIEKIMNCISLDEKDNIFEIGAGKGHFTAELVKRCNFVTAIEIDSKLCEVTRNKLLNYPNYQIVNDDILKFTFPSHNPYKIFGSIPYNISTNIIRKIVFESSATISYLIVEYGFAKMLLDTNRSLALLLMAEVDISILAKIPRYYFHPKPKVDSTLIVLKRKPAKMAFKERKKYETFVMKWVNKEYEKLFTKNQFNKALKHARIYDINNISFEQFVSLFNSYKIFNG	143.44	gnl|BL_ORD_ID|915|hsp_num:0	989			6	342	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0001409.1|Dutomycin_9 # 8730 # 9515 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.695	BGC0001409.1|Dutomycin_9 	8730	9515	-	Loose	350	24.6386	AAC(2')-Id	36.51	3002526	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(2')	ATGAGACTGGTCGATCTGTCGTCACCCGTCGACGCCCGGGGCTGGGAGCCCGAACCGGTGACCCACGAGGTGATCACACCGGCCGAGGGCGCCCGGCACATGGCCGAGGAGATGCGTGAGCACTTCGGCATCGAATTCGACCCGAGCGTGCTCGACGACGGCGAACTGCTGTCGATCGACACGCTGCGGCTCACCACCCACACCGGTACGCACATCGACGCGCCCGCCCACTACGGCACCCGCGCCTCCTACCGCGAGGGTCCGCCACGCACCATCGACGAGCTTCCGCTGGAGTGGTTCCACCGGCCCGCCGTCGTGCTCGACCTCACCGACGCGCCACCCGGAGCCGTCGGCGCCGACCGGATACAAGCCGAACTGGACCGGGTGGGCGCCGAGTTGGCGCCCCTCGACATCGTGCTCCTGCACACCGGAGCCGACCGGTGGGCCGGTACCGAGAAGTACTTCACAAACTTCGCTGGGCTCGACGGACCCGCCGTGCACCTCCTGCTCGACCTCGGAGTGAAGGTCATCGGCACCGACGCGTTCAGCCTGGACGCACCCTTCGGCGACATCCTTCAGCGCTACCAGCGGACCGGGGACCGGTCGGTCCTGTGGCCCGCCCACTTCACGGGCCGCGACCGCGAGTTCTGCCAGATCGAGCGCCTCGCCAACCTGGACCGGCTGCCCCGGCACGGCTTCACCCTCTCGTGCTTCCCCGTGAAGATCGCGGGCGCCGGAGCCGGCTGGACCCGCGCGGTCGCTTTCATCAACGACAACGAGGGCTGA	MRLVDLSSPVDARGWEPEPVTHEVITPAEGARHMAEEMREHFGIEFDPSVLDDGELLSIDTLRLTTHTGTHIDAPAHYGTRASYREGPPRTIDELPLEWFHRPAVVLDLTDAPPGAVGADRIQAELDRVGAELAPLDIVLLHTGADRWAGTEKYFTNFAGLDGPAVHLLLDLGVKVIGTDAFSLDAPFGDILQRYQRTGDRSVLWPAHFTGRDREFCQIERLANLDRLPRHGFTLSCFPVKIAGAGAGWTRAVAFINDNEG	MLTQHVSEARTRGAIHTARLIHTSDLDQETRDGARRMVIEAFRDPSGDSDFTDDFTDDDWDHALGGMHALISHHGALIAHGAVVQRRLMYRGPDGRGHALRCGYVEAVAVREDRRGDGLGTAVLDALEQVIRGAYQIGALSASDIARPMYIARGWLSWEGPTSVLTPTEGIVRTPEDDRSLFVLPVDLPDGLELDTAREITCDWRSGDPW	124.29	gnl|BL_ORD_ID|1297|hsp_num:0	1415			429	603	dibekacin; netilmicin; tobramycin; 6'-N-ethylnetilmicin; gentamicin
BGC0001409.1|Dutomycin_10 # 9522 # 10745 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=6bp;gc_cont=0.708	BGC0001409.1|Dutomycin_10 	9522	10745	-	Loose	550	77.7962	Nocardia farcinica rox	28.17	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGGAAGAACAGACGGACATCTGCATCGTCGGCGGTGGCCCCGCGGGCATGACCCTGGCGCTGCTGTTGCTGCGCTCCGGAGCGCGCGTCACCGTCGTCGAGCGCAGTTCCTCGCTCAGCCGCGAGTACCGCGGCGAGATCCTCCAGCCCGGCGGCCTCGCCGTACTCGACGAGATCGGCGTCCTCAAGGGCGCCACCGACCGCGGCGCGCACGTCCTGGAGCGGTTCCGGCTCGTCGAGCACGGCCGGGTGCTGATGGCCTTCGACTACCGCAAGCTGCAGCCGCCGTACAACTACCTGCTCAGTCTGCCCCAGGCACACCTGCTCGCCGAACTCCTCGACAGGTGCCAGGAGTTCCCGGGATTCCGCTACCTGGTGGCGCGGGTCAACGGCCTGATCCGTGAGGGCGACGCCGTGCGCGGTGTGTACGCCAAGGCCCAGGACGTCACCTACACGGTCCACGGCGCCTGTGTGGTCGCCGCGGACGGGCGGCACTCGCAGGTGCGCCGGCTCGCCGGGATCGACCACGTCCGCCAGGACGTCTTCGACCAGGACGTGGTCTGGTTCCGGCTGCCCGCCGAGGAACCCCTCGGCGAGGTCATGGTGAACCGCGCGGGCGGCAACCCCGTGCTCGCCTACGACTCGCACCCGGGCGCCCTCCAGATGGGCTGGACCCTGCCGAAGGGGGAGTGGAAGCGACTCGCCCCGCTGGGTATCGGCGAGGTGCGCCGAAGGATCGCCGAGGCGACCCCGCAGTTCGCGGAGCGGGTGGAAGGCACTCTGCGGAGTTTCGCCGACGTCTCGCTCCTCGACGTGTTCGGCGCCGCCGCCGAGCGCTGGACCGGCGACGGCCTCGTCCTCATCGGCGACGCCGCGCACACGCACGGTCCGCTCGGCGCCCAGGGCATCAACCTGGCGGTGCAGGACGCGGCGCTGCTCCACCCGATCCTGGTCGCCGCCGTCGCGGACGGCGACATGAGCGCCGGGCGCCTCGCGGAGTTCGAGCGGATCCGCAGGCCGCACATCAAGGCGGTCATGAAGTTCCAGGCCGTGCAGAGCCGGATGATGCTCTCCGCCGACAGCCTGGCCACCTTCCTGCGGCCGAAGCTCGCCCGTGTCGTGATGCGCACCCCGATCGGCACCAAGTTCACCAACCGGATCGCCTTCGGGGCCCCGGGCATCCGGGTCGCCGACAACCTCTTCACCGTCAACCAGAAAGAGTGA	MEEQTDICIVGGGPAGMTLALLLLRSGARVTVVERSSSLSREYRGEILQPGGLAVLDEIGVLKGATDRGAHVLERFRLVEHGRVLMAFDYRKLQPPYNYLLSLPQAHLLAELLDRCQEFPGFRYLVARVNGLIREGDAVRGVYAKAQDVTYTVHGACVVAADGRHSQVRRLAGIDHVRQDVFDQDVVWFRLPAEEPLGEVMVNRAGGNPVLAYDSHPGALQMGWTLPKGEWKRLAPLGIGEVRRRIAEATPQFAERVEGTLRSFADVSLLDVFGAAAERWTGDGLVLIGDAAHTHGPLGAQGINLAVQDAALLHPILVAAVADGDMSAGRLAEFERIRRPHIKAVMKFQAVQSRMMLSADSLATFLRPKLARVVMRTPIGTKFTNRIAFGAPGIRVADNLFTVNQKE	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	86.05	gnl|BL_ORD_ID|4834|hsp_num:0	5821			6	1113	rifampin
BGC0001409.1|Dutomycin_11 # 10758 # 11537 # -1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.738	BGC0001409.1|Dutomycin_11 	10758	11537	-	Loose	450	60.077	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	25.95	3004045	protein variant model	G93A	n/a	disinfecting agents and antiseptics; isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant fabI	GTGTCGGAACCGCAGACGCGCAGCGAAGTACCACCGCTGCCCGGCCTGAAGGGCAAGAGCGCCCTCGTCATCGGCGGAACGCGCGGAGTGGGCCGGGCGGTCACCGAGAAGCTGGCCGCGTCCGGCTGCGACGTCATCGCCACGTTCGCCCACTCGGAGGCGGACGCCGAGGCCTTGCTCGCCGACCTGAAGGACACGCCGGGCAGCCTGACGGCACTGCGCGCCGACGCGCGCCGGGCCTCGACGCCGCCCGAGCTGATGCGCGAGGTACGCGAGCGGCACGGACGCCTCGACATCCTGATCCACTCGGCCGCCTCGGCGCACCCCATGCCGACGCTCGGCATGCGCCTGAGGGAGGTGTACGCCGACACGGCGACCGCGGTGGTGCCGCTCGCGGCGTCCGCGGCGGCGTCCGCGGACCTGATGTCCGAGGGCGGCCGGATCATCGTCGTGTCGGCCAGCGTCGCCCGCGGTGTGGCTCCCCACATGGTCAGCCTGGGAGTCGCCAAGGCGGCCCTGGAGAGCCTGACCCGGTTCGTGGCGGTCGAACTGGCGAGCCGCGGCATCACGGTCAACGCGGTCTCGGCCTCCAAGCTCGACAAGGGGGCCGACACGACACGCCCGGAGGTGGCCCGCGCGATCGGCGCCCGCACCCCCGCCGGACGTCTCGCGACACCGCGGGACGTGGCGGACACCGTCGCGCTGCTCTGTCTGCCCGAGGCCCAGTGGATCACCGGCCATGTGGTCTCCGCCGACGGCGGCCTGAGCCTGCTGGCCTGA	MSEPQTRSEVPPLPGLKGKSALVIGGTRGVGRAVTEKLAASGCDVIATFAHSEADAEALLADLKDTPGSLTALRADARRASTPPELMREVRERHGRLDILIHSAASAHPMPTLGMRLREVYADTATAVVPLAASAAASADLMSEGGRIIVVSASVARGVAPHMVSLGVAKAALESLTRFVAVELASRGITVNAVSASKLDKGADTTRPEVARAIGARTPAGRLATPRDVADTVALLCLPEAQWITGHVVSADGGLSLLA	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	98.85	gnl|BL_ORD_ID|4712|hsp_num:0	2666			9	765	triclosan
BGC0001409.1|Dutomycin_12 # 11818 # 12831 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.716	BGC0001409.1|Dutomycin_12 	11818	12831	+	Loose	500	28.8758	chrB	46.67	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	GTGACGAACCTCCGCAGACTCGCTCTCGCCGCCGGTCACGCGGCCGCGCTCCGCGCCGCGGCGCAGCTGGGTGTCGCCGACGCGCTCGGCGAGGAACCCACGACCGCCGCCGAACTGGCGCGCGCGGTCAACGCCGAACCCGGCACCCTGGACCGGCTGTTGCGCGCGCTCAGCTCGCAGGGCGTGTTCACCGCCCAGGGCGACCGCTACGCGCACACGCCGGTCTCCCGACTGCTGCGCACCGACACCCCGCGCAGCCTGCGCGACATGGTCCTGTGGGCCACGGAACCCTGGACATGGGACGTGTGGCCGCACCTCGCCGACGCCGTACGCACCGGGAAGGGCGGTTTCAGCGAGGCGCACGGCAAGGACTTCTTCACCTATCTGTACGAGGACGCGCCGGAGTCGGCCGAGGTCTTCAACCGGGCCATGACACAGGCCAGCCGGCTGTCGTCGGCGGCAATCGCGGAGTCGCTCGATCTGCGCGGCGACCTCACGGTGGTGGATGTCGCCGGCGGCCACGGCGACCTCATCGCGACCGTCCTGGAGCGCGATCCGTCCCTCCAGGGCGCCCTGTTCGACCTGCCCGGCGTGCTCCCCGACGTCGACCCGCGGCTGCGTGAGGGAGGTGCGCTGCACGACCGCTGCCAACTGGTGGCGGGCGACTGCCGGGACTCGGTGCAGGTCGAGGCGGACGTCTTCATCCTGAAGAACGTGCTGGAGTGGGACGACGCGGGCACCGTGGCCGCGCTGCGCAACGTGGCCGCCTCGGCCCGTCCGGGCGGGCGGGTCGTCGTGATCGAGAACCTGGTCGACGGAAGCCCGGAGACGGGGTTCACCACGGCCATGGACCTGCTGCTGCTGCTCAACGTCGACGGCAGGAAGCACCTGCGCCAGAGCCTGCTGCGCCTGGTGGAGGAGGCCGGTCTCACCGTGACCGACGTCCGGCCGGTCGGACCGTATCTGCACATGATCGACAGCCGTGTTCCCGAACGCCGGGACACGGGTAACTGA	MTNLRRLALAAGHAAALRAAAQLGVADALGEEPTTAAELARAVNAEPGTLDRLLRALSSQGVFTAQGDRYAHTPVSRLLRTDTPRSLRDMVLWATEPWTWDVWPHLADAVRTGKGGFSEAHGKDFFTYLYEDAPESAEVFNRAMTQASRLSSAAIAESLDLRGDLTVVDVAGGHGDLIATVLERDPSLQGALFDLPGVLPDVDPRLREGGALHDRCQLVAGDCRDSVQVEADVFILKNVLEWDDAGTVAALRNVAASARPGGRVVVIENLVDGSPETGFTTAMDLLLLLNVDGRKHLRQSLLRLVEEAGLTVTDVRPVGPYLHMIDSRVPERRDTGN	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	120.36	gnl|BL_ORD_ID|274|hsp_num:0	305			273	363	tylosin; chalcomycin; mycinamicin
BGC0001409.1|Dutomycin_13 # 12989 # 13801 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.672	BGC0001409.1|Dutomycin_13 	12989	13801	-	Loose	400	34.6538	vanR gene in vanI cluster	26.32	3003728	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGAAGCTCGGAGTGCTCGGTACGTTAACCATCGATGATGTCGAAGTAGCGGAAATCCTGACGGCACCCAAGCCTCGCAGTGTGCTGGCGATGCTGATGCTCGAGCCCGGCCGTGCGGTGTCCACGGCGTCCCTGATCCAGGAGCTCTGGGACGAGCGCCCACCGCGCAGCGCGTCCACGACGCTCCAGACGTACGTCCTGCAGTTGCGCCGCATGTTCCGAGACATCTCACAGGTGATGGGCCAGCCCCCGTCGGACGCGCTCGTCACCAGGGTCCCGGGGTACCTCCTGCAGGCCGACCAGACCGAACACGACCTCAGCGCGTACGAGACCCTGGTCGAGCAGGGGCAGAAGTTCCTGGAGCAGGGTGACAACGAGAAAGCCGAAGGGCTGCTGTCGCGTGCGCTCGAACTCTGGCGTGGCGCCCCACTGAGCGACGTACGCCCGGGGCCGCTGCTCTACCCGCAGATCTGCGGCCTGGAGGAGAGCCGGCTCGCCGCGACCGAGATGCGCATCGAGGCCAACCTGCGGCTCGGCCGGCACCGCGAAGTGCAGAGCGAACTGACCGTTCTGGTGGGCAGCTACCCCCTGCATGAGGGGATCCGCGTCAAGCACATGCTGGCCCTGTTCCGGGCCGGCCGGCTGTCCTCCGCGCTCGACTCGTTCCACCAGTACCGCCACCGTCTGGTGACCGACCTGGGTCTCGAACCGTCCCCCCGCATACGGGGCCTGCAGCACGCGATGCTGTGCTTCGACCCCATGGCCGACTCGCTGGCGATTCTCGACCGTGTGGCGTCGGGTGTTTCCCACTGA	MKLGVLGTLTIDDVEVAEILTAPKPRSVLAMLMLEPGRAVSTASLIQELWDERPPRSASTTLQTYVLQLRRMFRDISQVMGQPPSDALVTRVPGYLLQADQTEHDLSAYETLVEQGQKFLEQGDNEKAEGLLSRALELWRGAPLSDVRPGPLLYPQICGLEESRLAATEMRIEANLRLGRHREVQSELTVLVGSYPLHEGIRVKHMLALFRAGRLSSALDSFHQYRHRLVTDLGLEPSPRIRGLQHAMLCFDPMADSLAILDRVASGVSH	MAANILIVDDEQAIADLVEVYLKNENYNLFKFYNGKDALDCIEKEKLDLAILDVMLPDVDGFSICRQIREKHNFPVIMLTAKEEEIDKITGLTLGADDYITKPFRPLELIARVKAQLRRFTKYNSAEPNQEEHVIAFSGLVLDMDTHECTLNEKKLSLTPTEFSILWVLCSNRGRVVSSEELFSEVWGDKYFTNSNNTVMVHIRHLREKMQDSAEHPKYIKTVWGVGYKIEK	116.38	gnl|BL_ORD_ID|2065|hsp_num:0	2246			474	645	vancomycin; teicoplanin
BGC0001409.1|Dutomycin_15 # 14005 # 14985 # -1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.662	BGC0001409.1|Dutomycin_15 	14005	14985	-	Loose	1200	43.1282	arnA	26.86	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGAGCGGCCCGCGGATTCTGGTCACCGGCGGCGCAGGTTTCATCGGCTCGCACTACGTGCGCGCCGTGCTGGCCGGGGAGTATCCCGCTTATGCCGATGCGGAGGTGACGGTCCTCGACAAACTGACTTACGCCGGAAATCCAGCCAATTTGGACGATGTACGGTGCGAACTCGTATGGGGAGATTTATGCGACCCCGAGCTGCTGGGCAAGGTCATACCTGGCCAGGATGTGGTCGTCAATTTCGCGGCGGAATCGCACGTCGACCGTTCCATCACCGGCGCCGCCGAATTCGTACGGACCAACGTGCTCGGTGTCCAGACCCTGCTCCAGGCCTGCCTGGAGGCGGGCACTCCACGCATCGTGCAGGTCTCGACGGACGAGGTGTACGGATCCATCGACGCCGGTTCGTGGGACGAGGACGCCCCGCTCCGGCCCCGCTCGCCCTACGCGGCGTCCAAGGCCGGCGGCGACCTGGTGGCCCGTGCCTACGCGATCACGCACGGCCTGCCCGTGTCGATCACCCGCTGCGGCAACAACTACGGGCCGCGCCAGTTCCCCGAGAAGGTCATCCCGCTCTTCATCAGCAGGCTGCTGGAGGGCAGGAAGGTGCCGTTGTACGGGGACGGCGGCAACATCCGTGACTGGGTGCACGTCGAGGACCACTGCCGTGGCGTGCAGCTCGTCGCCGAACGCGGTGCCCCGGGCGAGGTCTACCACATCGCGGGCACCGCCGAACTGACCAACCGTGAGCTGACCGAACGCCTGCTCGAAGCGTGCGGCCGCGGCTGGGACATGGTGGAGCACGTCGTGGACCGCAAGGGCCACGACCGTCGCTACAGCCTCGACGCCGGCAAACTGCGCGCGCTCGGCTTCACCCCTCGCATCCCCTTCGACGAGGGACTGGCCGAGACTGTTCGCTGGTATGTGGATCACCCGGAGTGGCGCATAGGTCAAAGCTTTGTTCAAAGGGAGGAGTAA	MSGPRILVTGGAGFIGSHYVRAVLAGEYPAYADAEVTVLDKLTYAGNPANLDDVRCELVWGDLCDPELLGKVIPGQDVVVNFAAESHVDRSITGAAEFVRTNVLGVQTLLQACLEAGTPRIVQVSTDEVYGSIDAGSWDEDAPLRPRSPYAASKAGGDLVARAYAITHGLPVSITRCGNNYGPRQFPEKVIPLFISRLLEGRKVPLYGDGGNIRDWVHVEDHCRGVQLVAERGAPGEVYHIAGTAELTNRELTERLLEACGRGWDMVEHVVDRKGHDRRYSLDAGKLRALGFTPRIPFDEGLAETVRWYVDHPEWRIGQSFVQREE	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	49.24	gnl|BL_ORD_ID|1513|hsp_num:0	1643			954	1749	polymyxin B
BGC0001409.1|Dutomycin_16 # 14982 # 15971 # -1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.702	BGC0001409.1|Dutomycin_16 	14982	15971	-	Loose	750	25.7942	MIR-6	37.84	3002171	protein homolog model	n/a	n/a	monobactam; cephalosporin	antibiotic inactivation	MIR beta-lactamase	GTGCCGGTGGGCAACAAGCCGGTGCTGTTCCACGGTCTGGAAGCGATCGCCGCCGCGGGGGTGACGGAGACCGGCATCGTGGTGGGCGACACCCGTGCCCAGATCCAGGCCGCCGTCGGCGACGGCTCGCGGTTCGGCCTGGAGGTCTCCTATCTGTGGCAGCGGGAGCCGCTCGGTCTGGCCCATGCCGTGAAGATAGCCCGCGACTTCCTCGGGGACGACGACTTCGTGATGTACCTGGGCGACAACGTCGTCTTCGACGGCATCACCGACTTCGTGGAGCGTTTCCGGGACCGGCGGCCCGCCGCGCAGATCATGCTCGCCCAGGTCGAGGACCCCCGGCAGTTCGGCGTCGCCGAGGTGTCCGCCGACGGCCGGGTGACCGGACTTCAGGAAAAGCCCCGCCGGCCACGGAGCGATCTCGCCGTCGTGGGCGTCTACCTGTTCAGCTCGGCCATCCACAAGGCGGTCGCCGAAGTGGAGCCCTCGGCCCGCGGCGAACTGGAGATCACCGACGCGGTGCAGTGGCTCATCGACCACGACCTGCGGGCGGAGGCCGCCGTCATGACCGGCTGCTGGAAGGACACCGGCAACGTGCCCGACATGCTGGAGGTCAACCGCCTGGTGCTGCGGTCCCTGGAACCGTCCAGCGCCGGGGTGGTGCGCGACAGCGAGATCAACGGCCAGGTGGTCGTCGAGCCCGGGGCGCGGGTGACCGGCTCCGTGGTCGTCGGCCCCGCCGTGATCGGCTCCGGCGCGACCGTCACCAACTCCCGTATCGGCCCGTACACCTCGATCGCCGAGGACTGCTGCATCGCCGACAGCTGGATCCGTGACTCCATCGTCATGCCGCGCGCCTCGATCACCGGGGTGCGGCCGCTGGAGTCCTCGCTGATAGGCCAGGACGTGGAGATCACCCGCACTCCCGAACCGCCCTCCGCCCACCGCCTCGTCCTCGGGGACCGCAGCCGAGTGCAGATCGCGTCATGA	MPVGNKPVLFHGLEAIAAAGVTETGIVVGDTRAQIQAAVGDGSRFGLEVSYLWQREPLGLAHAVKIARDFLGDDDFVMYLGDNVVFDGITDFVERFRDRRPAAQIMLAQVEDPRQFGVAEVSADGRVTGLQEKPRRPRSDLAVVGVYLFSSAIHKAVAEVEPSARGELEITDAVQWLIDHDLRAEAAVMTGCWKDTGNVPDMLEVNRLVLRSLEPSSAGVVRDSEINGQVVVEPGARVTGSVVVGPAVIGSGATVTNSRIGPYTSIAEDCCIADSWIRDSIVMPRASITGVRPLESSLIGQDVEITRTPEPPSAHRLVLGDRSRVQIAS	MMTKSLSCALLLSVTSAAFAAPMSETQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSISKTSTGVLGGDAIARGEIALGDPVAKYWPELTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEAYGVKTNVKDMASWLIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLANKSYPNPARVEAAYRILDALQ	86.35	gnl|BL_ORD_ID|1045|hsp_num:0	1136			210	321	
BGC0001409.1|Dutomycin_17 # 16061 # 17473 # -1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=5bp;gc_cont=0.713	BGC0001409.1|Dutomycin_17 	16061	17473	-	Loose	350	30.0314	vanD	24.53	3000005	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	GTGTTCCGCACCGTCCTCATCGCCAACCGGGGGGAGATCGCGCTGCGCGTCGCGCGCGCCTGCCGTGAACTGGGCATCCGGGTCGCTGTCGTGTACTCCACCGAGGACACCGACAGCGAGGTCGTACGGTACGCCGACGAGGCGGTCCGTATCGGCCCCGGTTCGGCTCAGGCCAGCTACCTCAGCATCCCGGCCGTCATCGAGGCCGCCCGGCGCACCGGAGCCGACGCCATCCACCCCGGCTACGGATTCCTCTCCGAGAACGCCGACTTCGCCGAGGTGTGTGCCGCCGAGGACATCACTTTCATCGGCCCGCCCCCGGAGGTGATGGAGGCGCTGGGCGACAAGTCCACCTGCCGCGCCCTCATGGCCGATGCCGGGCTGCCCCTGCTGCCCGGCACCCTGGACCCCGTCCCGTCGTCCCGTGAGGCCGAGGCGCTCGCCGCCGAGATCGGCTTCCCCGTGGTGGTCAAGGCGGTCGCGGGCGGCGGCGGCCGCGGTATCGGAGTGGCGTACGGCGCGGACGAGTTCCCCGCCGTCTACCGGGAGACCCGGCGCCACGCCGCCGCCGTCTTCGGGGACGGCAGGGTCTATCTGGAGCGCTATCTGCAGTCCGCCCGCCACGTCGAGATCCAGGTGCTCGCCGACCGCTACGGCAACGTGATCCACCTCGGTGAGCGCGACTGCTCGGTACAGCGCCGCCATCAGAAGCTGATCGAGGAGGCCCCGGCACCCGGCCTGGACCAGGACGTCCTCGCAGCGATGGCGGAACACGCCGTCCAGGGCGCCAAGGCGGCGGGTTACGTGGGCGCGGGCACCTTCGAGTTCCTCTACGACGGCAGCGGCCGCTTCTACTTCATGGAGGTCAACTGCCGTATCCAGGTGGAGCATCCGGTCACCGAACTGGTCACGGGCATCGACCTGGTCCATGAGCAACTGTGGGTGGCCGCGGGCCATCCGCTGCGGATCGGCCAGCAGGACATCGCGCCGCGCGGCTGCGCCGTCGAGTGCCGCATCAACGCCGAGGACGCCGACCGGGAGTTCATACCGACCCCCGGAGTCATCGACGAACTCGCCCTGCCGTCGGGCCCGTTCGTGCGCGTGGACACCCATGTACGCCGGGGCTCGCGCATCTCCGTCTTCTACGACCCGCTGCTCGCCAAGGTCACCGTCTGGGCCCCCGACCGGGAGCTCGCGCTGGCCCGGATGGGCCGGGCCCTGGACGAGGTCCGTGTCGACGGCAAGGGCATGCGTACCACGGCGGGTTTCCTCCGCTCGGTCGTCGACAGCGACGAGTTCAGCACGGCCCGGCACGACACCGGGCTCGTCGGCCGGCTCCTGGAGCCGGGACCGGCCGCCCGCGGGACCCAGGACCCGGGTCCCGCACAGGTGAAACCACCGAACGCCTCGTAG	MFRTVLIANRGEIALRVARACRELGIRVAVVYSTEDTDSEVVRYADEAVRIGPGSAQASYLSIPAVIEAARRTGADAIHPGYGFLSENADFAEVCAAEDITFIGPPPEVMEALGDKSTCRALMADAGLPLLPGTLDPVPSSREAEALAAEIGFPVVVKAVAGGGGRGIGVAYGADEFPAVYRETRRHAAAVFGDGRVYLERYLQSARHVEIQVLADRYGNVIHLGERDCSVQRRHQKLIEEAPAPGLDQDVLAAMAEHAVQGAKAAGYVGAGTFEFLYDGSGRFYFMEVNCRIQVEHPVTELVTGIDLVHEQLWVAAGHPLRIGQQDIAPRGCAVECRINAEDADREFIPTPGVIDELALPSGPFVRVDTHVRRGSRISVFYDPLLAKVTVWAPDRELALARMGRALDEVRVDGKGMRTTAGFLRSVVDSDEFSTARHDTGLVGRLLEPGPAARGTQDPGPAQVKPPNAS	MYKLKIAVLFGGCSEEHDVSVKSAMEVAANINKEKYQPFYIGITKSGAWKLCDKPCRDWENYAGYPAVISPDRRIHGLLIQKDGGYESQPVDVVLPMIHGKFGEDGTIQGLLELSGIPYVGCDIQSSVICMDKSLAYMVVKNAGIEVPGFRVLQKGDSLEAETLSYPVFVKPARSGSSFGVNKVCRAEELQAAVTEAGKYDSKILVEEAVSGSEVGCAILGNGNDLITGEVDQIELKHGFFKIHQEAQPEKGSENAVIRVPAALPDEVREQIQETAKKIYRVLGCRGLARIDLFLREDGSIVLNEVNTMPGFTSYSRYPRMMTAAGFTLSEILDRLIGLSLRR	137.03	gnl|BL_ORD_ID|759|hsp_num:0	824			180	774	vancomycin; teicoplanin
BGC0001409.1|Dutomycin_18 # 17480 # 18007 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.720	BGC0001409.1|Dutomycin_18 	17480	18007	-	Loose	620	26.1794	ROB-8	25.0	3005078	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	ROB beta-lactamase	ATGCCCACGCCCGACAGCGTTGCCACCCTCGACGCTCTGATGAGCGACGGACGCCCCGACACCCTTCCCTCGGTCCTGGAGGCCGCCAAGACGAGCATGATCGAGCTCTTGTCGGAGGCTCCCGTTCCGCCCTCCGCGGTCCGTGTGACGGTCGGCCCCGTCACGATCGAGATGGACTGGCCGGGCGCGGCCCCCGCGGCGGCCGCCGCACCTGCACCCGCCGCGCCCGCGACGGCCGCACCGGCCCCGAGTGCCACGGCACCGGACGCACAGTCGCCGCTCGACCACATCCACGCCCCGACGGTCGGGGTCTTCTACCGGGCGCCCGAACCCGGCGCCAAACCCTTCGTGACCGAGGGGGACACGGTGGTGCCCGGTCAACAGGTGGGTCTCATCGAGGCGATGAAGCTGATGATCCCCATCGAGTCCGACCGGCACGGCGTCATCGACGAGTTCCTGCAGCCCAACGGCGCCCTGGTCGAGTACGGCGACCCGCTGTGCTCCCTCGTCCCGGCCGACGGGCGGTGA	MPTPDSVATLDALMSDGRPDTLPSVLEAAKTSMIELLSEAPVPPSAVRVTVGPVTIEMDWPGAAPAAAAAPAPAAPATAAPAPSATAPDAQSPLDHIHAPTVGVFYRAPEPGAKPFVTEGDTVVPGQQVGLIEAMKLMIPIESDRHGVIDEFLQPNGALVEYGDPLCSLVPADGR	MLNKLKIGTLLLLTLTACLPNSVPSVTSNPQPASAPVQQSATQATFQQTSANLEQQYQARIGVYVWDTETGHSLSYRADERFAYASTFKALLAGAVLQSLPEKDLNRTISYSQKDLVSYSPETQKYVGKGMTIAQLCEAAVRFSDNSATNLLLKELGGVEQYQRILRQLGDNVTHTNRLEPDLNQAKPNDIRDTSTPKQMAMNLNAYLLGNTLTESQKTILWNWLDNNATGNPLIRAATPTSWKVYDKSGAGKYGVRNDIAVVRIPNRKPIVMAIMSTQFTEEAKFNNKLVEDAAKQVFHTLQLN	57.38	gnl|BL_ORD_ID|2797|hsp_num:0	3815			57	213	
BGC0001409.1|Dutomycin_20 # 19706 # 19963 # -1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.690	BGC0001409.1|Dutomycin_20 	19706	19963	-	Loose	500	23.0978	OXA-561	55.56	3005785	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCCAGAGCTGACCCTTGGCGAGCTCGCCCGCATCCTGCGCGAGTGCGCGGGCGAAGGCGAGAGCGTCGACCTCGACGGGGAGTTCGCGGACGTCCTCTTCGCCGACCTCGGATACGACTCGCTGGCCGTCCTGGAGACCGCGGCCAGGCTCAAACGGGAGTACGGCGTCGAGCTGACCGACGAAGAGGTCAACGAGGTCGGCACGCCGGGCAGGCTCCTCGAACTGGCCAGGCGCCAGATCGCCGCGACTTCATGA	MPELTLGELARILRECAGEGESVDLDGEFADVLFADLGYDSLAVLETAARLKREYGVELTDEEVNEVGTPGRLLELARRQIAATS	MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIHQGQTQQSYGNDLTRASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTLGDAMKASAIPVYQDLARRIGLELMSEEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQGNIVAFTLNLEMKKGIPSSVRKEITYKSLEQLGIL	31.02	gnl|BL_ORD_ID|3820|hsp_num:0	4890			402	456	cloxacillin; oxacillin; cefalotin
BGC0001409.1|Dutomycin_21 # 20001 # 21224 # -1 # ID=1_21;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.741	BGC0001409.1|Dutomycin_21 	20001	21224	-	Loose	750	100.523	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	30.73	3003463	protein variant model	G387D	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	GTGAACGCAGCCGTCGTCACGGGCATCGGAGTCGTCGCGCCGAACGGGCTGAGCACCGAGGAGTACTGGAGCGCCACCCTCGCGGGCCGCTCCGGCATCGGCCGCATCACCCGCTTCGACCCCGAGCGCTACCGTGCCACCCTGGCCGGCGAGATCCGCGGCTTCGACCCCGCCGCCCATCTGCCCAGCCGGCTGATCCCCCAGACCGACCACTCCACCCGGCTCTCCCTCGTCGCCGCCGACCAGGCCATCCGTGACGCCGGCCTGGACACCGGGCAACTGCCCGAGTACGGCGTCGGCGTGGTCACCGCCAACAGCGCGGGCGGTTTCGAGTTCGGCCACCAGGAACTCGACAACCTGTGGCGCCAGGGACCCGAGTACGTCAGCGCGTACCAGTCCTTCGCCTGGTTCTACGCGGTCAACACCGGCCAGATCTCCATCCGGCACGGTCTGCGCGGCCCCAGCGGGGTGCTGGTCGCCGACGAGGCGGGCGGCCTCGACGCCCTCGCCCAGGCCCGGCGGCTGCTGCGCCGGGACCTGAACGCCGTGGTCACCGGCGCGGTCGACGGATCCCTGTGCCCCTGGGGCTGGATCGCCCAGACCTCGACCGGACAGCTGAGCGCGGCGAAGGACCCGGCACTCGCGTACCGCCCGTTCGACGAGGAGGCCGCGGGCTTCGTACCGGGCGAGGGCGGCGCGATCCTGGTCGTCGAGGACGAGGCGGCCGCTCGTAAACGCCGCGCTCCCCAGGTACACGGCAGGCTTCTCGGATACGCCGCCACCTTCGACCCCAAGCCGGGCACCGCACCCGCCGACGACACGTCGGCGCTGCGCGGGGCGATCGAACTCGCTCTCGCCGACGCCGGTGCCGCACCCGATGACATCGATGCCGTCTTCGCCGACGCAGCCGGCATTGCGCACCTCGACCGGGCGGAGGCCGCCGCGCTCACCGCGGTCTTCGGCGGGCGCGAGCTCCCGGTCGCCATCCCCAAGACGCTGACCGGCCGGCTGGGCGCGGGCGCGGGACCACTGGACGTCGCCACCGCGCTGCTCGCCCTGCGCGACGGCGTCCTTCCCCCGGCGGCGCACACCCGGCCGTCGCCCCGGTACGGGCTCCAGGTGATCGTCGACCGGCCGCTGGAGCTCCGTATGGGCGCCGTGCTGGTCGTCGCCCGCGGCCTCGGCGGCTTCAACTCCGCGATGGTCGTGGGCGCGTCCCACTGA	MNAAVVTGIGVVAPNGLSTEEYWSATLAGRSGIGRITRFDPERYRATLAGEIRGFDPAAHLPSRLIPQTDHSTRLSLVAADQAIRDAGLDTGQLPEYGVGVVTANSAGGFEFGHQELDNLWRQGPEYVSAYQSFAWFYAVNTGQISIRHGLRGPSGVLVADEAGGLDALAQARRLLRRDLNAVVTGAVDGSLCPWGWIAQTSTGQLSAAKDPALAYRPFDEEAAGFVPGEGGAILVVEDEAAARKRRAPQVHGRLLGYAATFDPKPGTAPADDTSALRGAIELALADAGAAPDDIDAVFADAAGIAHLDRAEAAALTAVFGGRELPVAIPKTLTGRLGAGAGPLDVATALLALRDGVLPPAAHTRPSPRYGLQVIVDRPLELRMGAVLVVARGLGGFNSAMVVGASH	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	97.84	gnl|BL_ORD_ID|1968|hsp_num:0	1943			87	1242	isoniazid
BGC0001409.1|Dutomycin_23 # 22703 # 24133 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=7bp;gc_cont=0.692	BGC0001409.1|Dutomycin_23 	22703	24133	+	Loose	400	26.9498	salB	34.62	3007026	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	sal-type ABC-F protein	ATGGCACGTGACCATTTGTCGGCCGGGCACAGTCCCGGCCCGGAAGCCCGGTTCACCGAGTCGGCGGCGGCCACCGAGGACCGCGCGTCCGTCAAGGCCGCGCTCAACTGGCTGACGGCGCGCCGGGACGCGCACACCTTCGAGGTGACGCGCGTCCCCTTCGACGAGCTCCAGGAGTGGTCCTTCGCGGCGGACACGGGCGATCTCGTCCACCGCAGCGGCAAGTTCTTCACGGTCCAGGGCCACCGGGTGCACAGCGACTACGGGAAGGTCCCGCGCTGGGACCAGCCCATCATCAACCAGCCCGAGATCGGCATGCTCGGCTTCGTCGTCAAGGAGACCGACGGCGTCCTGCGCTGTCTGATGCAGGCCAAGATGGAGCCCGGCAACGTCAACGTGGTCCAGCTGTCGCCGACCGTGCAGGCCACCCGCAGCAACCAGAAGCGGGTACACCGCGGTTCGAGCGTGCGCTATCTGGAGTACTTCACCGAGCCCGGCCGGTCCGACGTCCTCGTCGACGTCCTGCAGTCCGAACAGGGCTCCTGGTTCCTCGGCAAGCGCAACCGCAACATCGTGGTCGAGACGACCGAGGACGTGCCGCCGCACGACGACTACCGCTGGATGACGATCGGCGAGATCCAGGAAATCCTGCGGATGGACAACATGGTGAACATGGACGCCAGGACGGTGCTGTCCTGTGTCCCGTTCGCCCGCCCGACCGGAGCACCCGCGCCGGGGCCGCACGGCGACTTCCGCGCCGCCCTGCGCCGTTCGCTGGCACCCGAGGAGGGCGCCCTGCACCCGCCGAGCGCGGTGCTCAGCTGGTTCACGGACACCACGGCCCGGCACGAACTGCGCACCGAACGCGTTCCGTTGAACCGGATCGAGGGCTGGAACCGCACCGCGGACGCGATCAGTCACGCGGAGGGCCGGCACTTCTCGATCATCGGCGCCCAGGTGACGGCGGGCAGCCGCGAGGTACTGAACTGGACGCAGCCGCTGCTGGCCCCGCACGGTCTCGGCCTGGCCGCGCTGCTGGTCAAGAACATCGACGGGGTGCTGCACGTCCTGCTGCACGCCCGGCCCGAGGGCGGCCATCTGCACGGCATCGAGCTGGCACCCACCGTGCAGTGCACCCCGGACAACTACCGGGGCCTGCCCGACGGCCACCGGCCGCGGTTCCTCGACCAGGTGACCGGCGTACCCCAGGAGCGGGTGCGCTTCGACGCCGTGCAGTCCGAGGAGGGCGGCCGATTCCACCACGCGGAGTGCCGCTACACGGTCATCGAGGTCGAGGACGACTTCCCCATCCACGAGCCCGAGGGATACCGGTGGTTGACAATGCATCAGGTGACGCGGCTGCTGCGCCACAGTCACTATCTCAACGTCCAGGCACGCAGCCTCGTCGCCTGTCTGCACAGCCTGTGGTGA	MARDHLSAGHSPGPEARFTESAAATEDRASVKAALNWLTARRDAHTFEVTRVPFDELQEWSFAADTGDLVHRSGKFFTVQGHRVHSDYGKVPRWDQPIINQPEIGMLGFVVKETDGVLRCLMQAKMEPGNVNVVQLSPTVQATRSNQKRVHRGSSVRYLEYFTEPGRSDVLVDVLQSEQGSWFLGKRNRNIVVETTEDVPPHDDYRWMTIGEIQEILRMDNMVNMDARTVLSCVPFARPTGAPAPGPHGDFRAALRRSLAPEEGALHPPSAVLSWFTDTTARHELRTERVPLNRIEGWNRTADAISHAEGRHFSIIGAQVTAGSREVLNWTQPLLAPHGLGLAALLVKNIDGVLHVLLHARPEGGHLHGIELAPTVQCTPDNYRGLPDGHRPRFLDQVTGVPQERVRFDAVQSEEGGRFHHAECRYTVIEVEDDFPIHEPEGYRWLTMHQVTRLLRHSHYLNVQARSLVACLHSLW	MLFLFEEKPLEIENKQLIKRLSFHIEDHEHLALIGVNGIGKSTLLHHIHKNELIDTAMMEQDLSKHDDIDVMDYVMSAYPKLVELRKDLSDIDSLNSYIELDGYNVENNIIIEGNKLGLSSTHFEQKIGTLSGGEQTKVSFLKVILSDAPLLLIDEPTNHMDKEMKVWLIKAFKSEQRAILFVSHDREFLNETPDAILELTKDGATRYSGHYDDYKNQKDIEIETEKLKYEKEQKEQKAIEESIKKYKEWYQRAAQKASVRSPYAQKQLSKLAKRFKSKEHQLNRKLEESKSDNPLEENKSFSIENNEFKSHYLVRFENVSFSYKSREIFKDTYFEIKRNQTVIIEGKNGSGKSTLIQLILGNLLPMSGAVKKHPDLDIGYFSQDFQNLNPNNSVLEEVMDIENMMITDARTILASFYFDKSRMNDKVRQLSMGEKCRLQFVKLYFSNPHILILDEPTNYFDISMQEKIIQLIQSFNGAVIIVSHDEIFKDEIRDQVWKIENCKLIHENVSINTPIDAESMKDELKILEQYTDERNKETDF	87.99	gnl|BL_ORD_ID|4725|hsp_num:0	5737			1185	1263	lincomycin; clindamycin; virginiamycin M1; tiamulin; retapamulin
BGC0001409.1|Dutomycin_24 # 24130 # 25128 # 1 # ID=1_24;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.732	BGC0001409.1|Dutomycin_24 	24130	25128	+	Loose	920	26.1794	OpmD	43.33	3000809	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACCGGGCGCGGAGCACCGCTGCGGATCGGAGTGCTCGGCTGCGGCGGAATCGCCATGCGCCGGATGCTGCCCGCGATGGCCCGCAACCCGGCGGTCGAGATCGCCGCGGTCGCCAGCCGCGACCGGGAACGCGCCGAGGCGGCCGCGCACCGGTTCGGCGCGGCTCCGGTGCACGGCTACGACCGGCTGCTGGAACGGGACGACATCGCCGCTGTGTACGTACCGCTGCCGCCCGCACTCCACGCGCCCTGGACGGCACGGGCGTTGAAGGCGGGCAAGCACGCCCTGGTCGAGAAGCCGATGGTCACCGGCGCCCAGGAGGCCCGGGATCTGGCCGCCCTCGCGGACGAGGGACAGCTCGTGCTGATGGAGAGCTTCATGTTCCTCCACCACACACAGCACGCCACGGTCACCGCCCTGCTGGAACGCGGCGAAATAGGTGAACTCCGGGCCGTCACTGCGGAGTTCGGGTTCCCGCCGCTGCCCGCACCGGACATCCGCCACCGGCCCGAGCTCGGCGGGGGCGCCCTGCTGGACGCCGGCGTCTACACGCTGCGGGTGACCCAACTCCTGCTGGGCGGCGCGGTGTCGGTGATCGGTTCGACCTTGACGAACGACGAGTCGTACGGGGTCGACGTGGCCGGCGACGCGCTGCTGCGCGGCGACACGGGAGTCACCTCCCACGTGTCCTTCGGCTTCCGACACGCCTACCGCTCGGCATACACCCTGTGGGGCAGCAGCGGACGGATCGTCCTCGACCGCGCCTTCACGCCTCCGCCCACGCACCGGCCCGTGCTGCGGGTCGAACGGCAGGACCAGGTGGAGGAGTTGACGCTCGCCGCCGACGACCAGTTCGCCAACATCGCCGGCCGGTTCGCGGCGCTGGCGCTGGGCGACGGGGACCCGGCGCCCGAACGCGCGGCGGCCGTTCGGCAGGCGGAACTGGTCGACGCCGTACGCGATGCCGCGCGGAGCGGTCCGGGGAGCCCGCCATGA	MTGRGAPLRIGVLGCGGIAMRRMLPAMARNPAVEIAAVASRDRERAEAAAHRFGAAPVHGYDRLLERDDIAAVYVPLPPALHAPWTARALKAGKHALVEKPMVTGAQEARDLAALADEGQLVLMESFMFLHHTQHATVTALLERGEIGELRAVTAEFGFPPLPAPDIRHRPELGGGALLDAGVYTLRVTQLLLGGAVSVIGSTLTNDESYGVDVAGDALLRGDTGVTSHVSFGFRHAYRSAYTLWGSSGRIVLDRAFTPPPTHRPVLRVERQDQVEELTLAADDQFANIAGRFAALALGDGDPAPERAAAVRQAELVDAVRDAARSGPGSPP	MKRSYPNLSRLALALAVGTGLAACSVGPDYQRPQSPPPRVASEHLGEFSGERREAPWWSFFDDPQLVRLVDQALARNHDIREARANLRSARALFDDRWLDQLPQVTSQAGYSRSIEQQLDYDGEPRRRLAESYRAGFDAQWEIDLFGRLGRLSDAALARAEAADADLRLVRLSIAADTARAYFEIQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEDVENAQANLLRSEAAIPPLTTALESARYRLDVLRGEAPGSGAPILDGGAAAPLAKNLPLGDVDRLILQRPDVVSAERQLAASTEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPSVSWPAFRLGNVRARLRAVEAQSDAALARYQRSLLLAQEDVGNALNQLAEHQRRLVALFQSATHGANALEIANERYRAGAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGSGDLAPGAGQLAAGETAGANR	68.17	gnl|BL_ORD_ID|450|hsp_num:0	442			1326	1416	acriflavine; tetracycline; norfloxacin
BGC0001409.1|Dutomycin_27 # 26871 # 28166 # -1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=3bp;gc_cont=0.681	BGC0001409.1|Dutomycin_27 	26871	28166	-	Loose	1000	28.1054	efpA	26.03	3003955	protein homolog model	n/a	n/a	rifamycin antibiotic; isoniazid-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGACATACGCAGCGCAATGCTGGAACTGACCCGGAAATTCCACCAGGAGCAGACCGAGGAGAGCTTCGTCCCCGGAGAGACGGCGATCCTCACCTCGGGTGCGGTGCTGGACGAGGAGGACCGGGTCGCCTTCGTCGAAGCGGCTCTGGAGATGACGATCGCCGCCGGGCCGCGGGCCCGGACCTTCGAGAGCCGGTTCGCCCGCGCCATGAAGGTGCGCAAAGCGCATCTGACCAACTCCGGTTCCTCGGCCAACCTCCTCGCGCTCAGCGCCCTCACCTCACCGCAGCTGGAGGACGCCCGTCTGGTCCCCGGCGACGAGGTGATCACGGTGGCCACCGGCTTCCCGACGACCGTGAACCCGGTCCTGCAGAACGGCCTGGTCCCGGTCTTCGTCGACATCGAACTGGGCACCTACAACACGACGCTGGAGCGGATCGAGGAGGCGATCGGACCGCGCACCCGCGCCATCATGGTCGCGCACGCGCTCGGCAACCCCTTCCAGGCGGCCGAGATCGCCGAACTCGCCTCCCGGCACGACCTGTTCCTCGTCGAGGACAACTGCGACGCGGTCGGCTCGTACTACCAAGGACGCCTCACCGGCACCTTCGGCGACCTCTCGACCGTCAGCTTCTATCCCGCCCACCACCTCACGATGGGCGAGGGCGGCTGTGTACTGACCGGCAATCTGGCGCTCGCGCGGATCGTCGAGTCCATGCGGGACTGGGGGCGCGACTGCTGGTGCGAGCCCGGCGAGGACAACCGCTGTCTGCGCCGCTTCGACTACAGCTTCGGCACGCTGCCGCAGGGATACGACCACAAGTACGTGTTCTCGCACGTCGGTTACAACCTCAAGACCACCGACGTACAGGCGGCGCTCGGCCTGAGCCAGCTGCGCCGGCTGGAGGAGTTCGGAACGGCGCGGCGGCGCAACTGGCAGCGGCTGCGCGACGGACTCCAGGACGTTCCCGGGCTGCTGCTGCCCGAGGCGACGCCCGGCAGCGACCCCAGCTGGTTCGGCTTCGTGCTCACCGTGCTGCCCGACGCGCCGTTCACCCGCAGCGCCCTGGTGACCTTCCTGGAGGACCGGAAGATCAGGACCCGCCGGCTCTTCGCGGGCAACCTCACCCGCCATCCCGCCTATGAGGGGCGTAACTTCCGGGTGGTCGGGGAGCTGACCAACAGCGATGTCACCACCGAGGCGACCTTCTGGATCGGGGTGTATCCCGGCATCACCCCGGAGATGGTCGACTACATGGTCGCGTCGATACGGGAGTTCGTGGCCGCGGCCTGA	MDIRSAMLELTRKFHQEQTEESFVPGETAILTSGAVLDEEDRVAFVEAALEMTIAAGPRARTFESRFARAMKVRKAHLTNSGSSANLLALSALTSPQLEDARLVPGDEVITVATGFPTTVNPVLQNGLVPVFVDIELGTYNTTLERIEEAIGPRTRAIMVAHALGNPFQAAEIAELASRHDLFLVEDNCDAVGSYYQGRLTGTFGDLSTVSFYPAHHLTMGEGGCVLTGNLALARIVESMRDWGRDCWCEPGEDNRCLRRFDYSFGTLPQGYDHKYVFSHVGYNLKTTDVQAALGLSQLRRLEEFGTARRRNWQRLRDGLQDVPGLLLPEATPGSDPSWFGFVLTVLPDAPFTRSALVTFLEDRKIRTRRLFAGNLTRHPAYEGRNFRVVGELTNSDVTTEATFWIGVYPGITPEMVDYMVASIREFVAAA	MTALNDTERAVRNWTAGRPHRPAPMRPPRSEETASERPSRYYPTWLPSRSFIAAVIAIGGMQLLATMDSTVAIVALPKIQNELSLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRTFIVGVALFTISSVLCAVAWDEATLVIARLSQGVGSAIASPTGLALVATTFPKGPARNAATAVFAAMTAIGSVMGLVVGGALTEVSWRWAFLVNVPIGLVMIYLARTALRETNKERMKLDATGAILATLACTAAVFAFSIGPEKGWMSGITIGSGLVALAAAVAFVIVERTAENPVVPFHLFRDRNRLVTFSAILLAGGVMFSLTVCIGLYVQDILGYSALRAGVGFIPFVIAMGIGLGVSSQLVSRFSPRVLTIGGGYLLFGAMLYGSFFMHRGVPYFPNLVMPIVVGGIGIGMAVVPLTLSAIAGVGFDQIGPVSAIALMLQSLGGPLVLAVIQAVITSRTLYLGGTTGPVKFMNDVQLAALDHAYTYGLLWVAGAAIIVGGMALFIGYTPQQVAHAQEVKEAIDAGEL	81.32	gnl|BL_ORD_ID|2188|hsp_num:0	2427			1191	1395	rifampin; isoniazid
BGC0001409.1|Dutomycin_28 # 28171 # 29121 # -1 # ID=1_28;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.752	BGC0001409.1|Dutomycin_28 	28171	29121	-	Loose	600	25.0238	PME-1	65.0	3006973	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	PME beta-lactamase	GTGAAGGCGCCCGGCACCGTGAACGCCGTGGTCGTCGGCGGCAGCGGCTTCCTCGGGCGGCACATCTGCGCCGCCCTCACCGCCCGCGGCGCCCGCGTCCTGTCGGTCGCCAGGCGTCCCGCGCCCGGTGTGCCCTCCGCCCGGATCGACCTCGTCGGCGGACCGCCGGCCGCGCTCGCCGACGTACTCGTCGACCATGGAGCGACCGTCGTCGTGAACGCCGCCGGGGCGGTGTGGAACTACGACGACCGAGCCCTGGACGAATCCAACGTCGTGCTCGTGGAACGGCTGCGGGACGCGGTGGCGAAGGTGCCGCACCGGGTGCGCGTGGTGCACCTCGGCTCGGTCTTCGAGTACGCGATGCCCGAACCCGGCCACCCCCTCACCGAGGACGCGCCGCTGAACCCGTCTACCGCCTACGGCAGGACCAAACTGCTGGGCAGCCGGACCGTCCTCGACGCCACCCGGGCGGGTCTGCTGGACGGCGTGGTGCTCCGTGCGACGACGTGCGCGGGGCCCGGGCTGCCGCCCGCCGGTCTGCTCGGCCGGGTCGCGGCCGAGCTGCGCACCGCCGCCCTGCGCGGCGAACCCGCGGTGATACGGCTCGCGCCGCTCACCGCCGAACGCGACTTCGTGGACTGCCGCGACCTCGCCGATGCCGTGGCCGCCGCCGCGACCGCTCCCGTCGTCGGACGGGCGGTCAACATCGGCAGCGGTACGGCCGTGAGCGTGCGCCGGCTGGTGGACCTGCTCGTCTCCGTGAGCGGAGTGCCCGCCACGGTCGTCGAGGAGGGCTCCGCCGACGGGCGCAGCGCCGGGGTCCACTGGCTCGCCGTACACACCGGGCTCGCCGAGCGGCTGCTCGGCTGGCGCCCCCGGCACAGCCTGGCCACGACGGTCGAGGCGATGTGGAGCGAGGCCATCACCAACGCCGAGGAAGGGCCTGACTGA	MKAPGTVNAVVVGGSGFLGRHICAALTARGARVLSVARRPAPGVPSARIDLVGGPPAALADVLVDHGATVVVNAAGAVWNYDDRALDESNVVLVERLRDAVAKVPHRVRVVHLGSVFEYAMPEPGHPLTEDAPLNPSTAYGRTKLLGSRTVLDATRAGLLDGVVLRATTCAGPGLPPAGLLGRVAAELRTAALRGEPAVIRLAPLTAERDFVDCRDLADAVAAAATAPVVGRAVNIGSGTAVSVRRLVDLLVSVSGVPATVVEEGSADGRSAGVHWLAVHTGLAERLLGWRPRHSLATTVEAMWSEAITNAEEGPD	MFLYFTQIRAWPLAALLLFMLAACAGAPRAPDDATDTASDALAALELRNGGRLGVFALDAGSGRSLGWREDERFGMCSTFKLLLAATVLDAARQGRLDGTAPIHFSDDDLVPHSPVLREHLALGSSTLTAPELARATQLTSDNAAANLLIRKLGGPEAVTALWRASGDEVSRLDRLEPDMNLLPPGDLRDSTSPRAMAQHVARLFTSEMLVPEDRERLREWMVETGTGLARLRAATPPHWQAGDKTGSAIAPLMPNKTHDVAVFWPPGRAPVIVAAYYESDAHHAGRIRAQDEAVLAQVGRIAVAWAGD	102.27	gnl|BL_ORD_ID|4560|hsp_num:0	5630			240	300	
BGC0001409.1|Dutomycin_29 # 29118 # 30308 # -1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.746	BGC0001409.1|Dutomycin_29 	29118	30308	-	Loose	700	46.595	oleD	25.06	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCGAGTGCTGTTGACCACCTGGGCCGCACCGGGGCATCTGTTCCCGATGGTCCCACTGGCCTGGGCTTTCCAGGCCGCCGGACACGAGGTACGGGTCGCGGGCCCGCCGTCCTGCCAGGACGCCGTCACCCAGGCGGGACTGTCCGCCGTCGAGGCCGGCGACCAGGCCGCGATCGCCGGGCTGCCCAAGCCGCCCGAACTGGCGGCCTGGGGGCGCCCGGCCCGCTGGCCCAGCGGATGGTCGGCCGACCTGGATCTGCTGGACACCGGGCAACGCCGGGTGATCCGCGCGCTGTACGAGAAGCAGTGTGCCGTCGCCGGCCTGATGCTGGACGACCTGATCGCCTTCGCCCGCTGGTGGCGCCCCGACCTGATCGTCCACGACGTGCTCTCGATGGCCGGACCCGTACTCGGTGCCGTGCTCGGGGTGCCCGCGGTCGGCCACGGCTGGGAGATCGGCAGCACACTGCACCCGCCGACCGGTGACTCCGACACGGAACCACTGCCCGCCTACCTCGAACTCTTCGAGCGGTACGGCGCCGAGGTCACCGAGCCGGTCGGCTGGGTCGACCCGTGCCCGCCCTCGCTGCGGCCCCCGGACGGCCGCCCGGTGCGGCGGCTGCCGATGCGGTGCGTGCCGTACAACGGCTCGGGCCGCCAGCCCGGTTGGCTCGCCGAGCGCGGCCGGCCCCGGGTCTGTGTGACCGCCGGGGTCGCCGGCGCCCGCTACCGCGACCCCGGCGGGCCCGACGTCCTCGCGCTGACCCTGGCGTCACTGGCCGCCACCGAGGCCGAGATCGTGCTGGCGCCGAGCGGTCCCGTTGCGGAGGAAGAGCTGCCGGACCAGGTGCGCGACGCCCGCGGGATCCCGTTCCGCATGCTGCTGCCCACCTGCGACCTCGTGATCCACCACGGCGGCGCGGGCACCGCGCTCACCTCCGTGGTCCTGGGCGTCCCGCAACTCGTCGTGCCGCCCTCACCGATCTGCACAGAGATCGGCCACGGGGTCGTGCGCGCCGGAGCGGGCGCGATGCTCGACCGTCTCGACAGCACCGAACTGCTGCTGAAGACGGCCACCGAGATGCTTGCGGCACCCGAGCCGTATCGGGCGGCCGCGGAGCGGGTGGGCTCGGAGACGGCGGCGCTGCCGTCCCCGAGCGCCCTTGCGGCCGAACTCGTGGCGTCGTGA	MRVLLTTWAAPGHLFPMVPLAWAFQAAGHEVRVAGPPSCQDAVTQAGLSAVEAGDQAAIAGLPKPPELAAWGRPARWPSGWSADLDLLDTGQRRVIRALYEKQCAVAGLMLDDLIAFARWWRPDLIVHDVLSMAGPVLGAVLGVPAVGHGWEIGSTLHPPTGDSDTEPLPAYLELFERYGAEVTEPVGWVDPCPPSLRPPDGRPVRRLPMRCVPYNGSGRQPGWLAERGRPRVCVTAGVAGARYRDPGGPDVLALTLASLAATEAEIVLAPSGPVAEEELPDQVRDARGIPFRMLLPTCDLVIHHGGAGTALTSVVLGVPQLVVPPSPICTEIGHGVVRAGAGAMLDRLDSTELLLKTATEMLAAPEPYRAAAERVGSETAALPSPSALAAELVAS	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	95.42	gnl|BL_ORD_ID|1253|hsp_num:0	1367			24	1116	erythromycin; tylosin
BGC0001409.1|Dutomycin_30 # 30325 # 36822 # -1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.736	BGC0001409.1|Dutomycin_30 	30325	36822	-	Loose	750	80.4925	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	28.68	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGCCCATCGCGATCGTAGGCATCGGGTGCCGCTTTCCCGGCGCGCGCGGAGCCGACGAGTTCTGGTCGCTGCTCCGCGCGTCACGCGATGTGATCTCCGAGGTTCCGGCAGACCGCTTCGACGTCGACGCGTTCCACGAACCCGGCCCCGTCAAGCCCGGGAAGATCAGCACGCGGTACGGCGGATTCCTGGACCACGTCGACGAGTTCGACGCCGTCTTCTTCGGGGTCGCTCCCAAGGAAGCGGCGCACATGGACCCGCAGCAGCGCCTGCTCCTGGAGACGACGTACGACGCGCTGGTGGACGCCGGGATCGCCGCCGACACCCTCGCCGGCAGCAGCACGGGCGTCTTCGTCGGCCAGCTCACCGCCGACTACTGGGACCTGCTCAGCCGTGAGAGCGACCTCGACATCTACGCCAACACGGGCACGACCCGCGCGGTCACCTCGGGACGGGTGTCGTACGCCTTCGATCTGCGCGGGCCCAGTCTGACGCTCGACACGGCCTGTTCGTCGGCCCTGACGGCGGTGCACCTGGCCTGCGACAGCCTGCGCAACGGCGAGTCGTCCCTCGCCCTGGCCAGCGGTGTCAACCTGGTCTTGCAGCCGGAGCCGAGCATCACCTTCTCCCAGGCCGGAATGCTGGCGCCCGACGGCCGGTGCAAGTTCGCGTCGCCCGCCGCGGACGGCTTCGTGCGCAGCGACGGCATCGCGACGGTCGTACTGAAGCGGCTGGACCAGGCGGAGGCCGACGGCGACGACATCTACGCGGTCGTCCTCGGCTCGGCCGTGACCAGCGACGGCGAAGGCAGCGGCTATCTGCTCACCCCCTCGGTGGAGGGCCAGGAAAGGACCCTGCGCTCCGCCTACCGCAACGCCGGCGCCGACCCCGCCGCGGTGGGCTACGTCGAGGCCCACGGCACGGGCACCGCGATCGGCGACCGGGTCGAACTGACCGCGCTGGCCCGCGTCCTGGGCGAGAACCGCCCCGCCGGCGAGCCGTGCCGGGTGGGCTCGGTGAAGACCAACATCGGGCACACCGAGGCGACCGCCGGACTCGCCGGACTGATCAAGACCGCCCTGTGCCTCAAGCACGGGCGGATCCCGGCGAGCCTGCACGCCGATACCCTGACCGACTCCGTCGACTGGGACGAACTGCCGCTGGTCGTCCAGCGCGAGCCCGTCGCATGGGAGGCGCGGGGACCGCGGCTCGCCGGAGTGAGCTCCTTCGGGATCTCCGGCACCAACGCGCACGTCGTCCTGGCCGAGCACACGCCCGCCGCTCCCGAGGCCAAGGAGACACAGCCGGCGCCGGACGCCGAGGACGAGACCGGCCCGGTGCTGCTGCCGCTGTCCACCCGCGGCCCGGCCGCGCTGCGCCGGGCGGCCGCGGACATGGCCGACTTCCTCGGCCCGGACGGTGCGGGGAGCGCGATCCCGCTCCGGGACATCGTGGCGACCGCCGCCACCCGCAGGCAGCACCTCGACAGCCGGGTCGCCGTCGTGGGCGGCACGCACGACCAAATGGCCGAAGCCCTGAGGGCGTTCCACGACGGAGCGCTCCCCTCGGGGGCCGGCCGCGCGGCCGACGACGTGGAGGACAAGCCCGTCCGTACGGTCTTCGTCTTCCCCGGCCAGGGTTCGCAGTGGGTCGGCATGGGCCGGGAACTGCTCGCCACCTCGCCGGCCTTCCGCGACGCCCTGACGCGCTGCGACGAGGCGGTACGGGCCGAGACCGGCTGGTCGGTCCTCGACCGTATCGCCGACGACGCGCCGCTCACCGAGATCGACGTCATCCAACCCACGCTCTGGGCGATGGAAGTGGCCCTCGCGCACCTGTGGCGGTCCTGGGGAGTCGAGCCGGACGCCGTCGTCGGGCACAGCATGGGCGAGGCGGCCGCGGCGTGCGTGTCGGGCGCGCTGTCCGTCGAGGACGCGGCGGCCGTGATCTGCCGGCGCAGCCGTCTCCTGCGGCAGGTCGCGGGCCAAGGAGCCATGGCCTTCGTCGAGTTGACCGCCGAGGAGGCGGAGCGGGAGATCGCCGACCACGCCGACCGGGTGTCCGTCGCCGTGATCAACGGCCCCACCTCCACCGTGCTGGCCGGAGACCCGGGGGCGCTGGAGGAGATCCTGGACCGCCTGAAGCAGCGGGACGTCTTCGGCCAGCCGATCAAGGTGGACGTCGCCTCGCACAGCCCCCAGATGGATCCCCTGCGCGAGCAGCTCCTCGAAGAGCTCTCCTTCGTGCGGCCCCGCTCCGGCAAAGTCCCGTTGCACTCCACCGTGCTCGACGAGGTGCTGGACGGCTCCCAACTCGGCACCGGCTACTGGGCGTTGAACCTGCGGGAGCCGGTGCGCTTCGGTCCCGTGGTGCAGGGGCTGCTGAACACCGGACGTACGCTCTTCATCGAGATGAGCCCCCACCCGGTGCTGGTGCCCGCGGTGCTCGAATGCCTCTCCCTGGCCGGGGCGAACGCCGGCGTGGCGGTGCCCTCGCTGCGCCGGGACGAACCCGAGCGCGCGACCCTGCTGGACGCCGTGGCCACGCTGTACACGGCGGGTGTCCCCGTCGACTGGCACGGCCTCGGCCAGGAGGGGAGCCCGGTACGGCTGCCCAAGTACCCCTGGCAGCGCGGCAGCCACTGGTACACGCCGAGCCGGCCCGTCGCAATGCCCCTCGCGCGCGGAGCGGCCGCCCCGGGGCACCCCCTGCTGGGCCCACGGCAGACGGGTGGACCCGACCTCGTCCGGGAGGGACGGCTGGACCTCGCCGGCGCCAACGCCTACCTCGCCGACCACCAGGTGCAGGGCGCCGCCCTGCTGCCCGGCACCGCGTACGTGGAGATGATGACCGCGGCGGCCCGCGAGGCGTGCGCACCCCACCGGCCCGCCCTCACCGAACTCACCTGCCACCGGGCCATGTTCCTGCGCCCCGGCGAAGAGCCGCTCGTCCAGGTGCGGATCACCGGGGCTGGTTCACCGGATCCGCGTATCGAGGTCCGCAGCAGCGTGGACGGCGAGCCGATGATCGTGCACGCCACGGCGCGGATCCTCACCGACGGCCCGCCGCGGCGCCCGGCGGACGACACACTTGCGTCCCGGTCGGCGGCGCGCGAACGGGCCACCGACCACTGGAGCGGAGCGGACTTCTACGCCGACTCCGCGCGCAGCGGCAACATCTGGGGCCCGGCCTTCCAGGGGATCACCGAACTGTGGCGCAGGGACGGCGAGGCGCTCGCCCGGGTCCAGACGCCGCCCGCACTGCCTGCGACGGGCGACGCGCAGATCTTCCACCCCGCCCTGCTGGACGCCTGCGCCCAGGTGCTCTCGGCCACCGTCACCGGCCAGGACGGCGCCGCCTCCGAGGTGTTCGTGCTGGCGAGCATGGACCGGGTCAGTCTGTACGGCAGCCCCCAAGGACCGCTGTGGAGCCATGCCGTGCGCACCTCCCGGGACGACGTCTCCTACGTCGGGGACATCACCGTCACCGACGAGGACGGCACGGTCCTCGCCGAACTGCACGGCGTACGGCTGCGCTACCTGGAACGCGAGGGCGTCCGACCGGGCGACGTGCGCCCGCGCGCACGCCGCGCAGGCACGCCGGACGACGACCGGGAACTGTCCGACTGGCTCTACGAACTCGACTGGCGGCCCGCGCCGCGCCGCGCCGGAGGGGAACTCCCGGACGGCCCCTGGCTGGTCTTCGCGGACCGGCACGGCATCGGGACCGCGCTCGCCGAGCAGCTGACCGCGGCGGGCCGGACCTGCGTGCGGGTGTCCGCCGGTGCCGGATATCGCAGGCTGAGCGACACGGCGGTCGAACTGGACCCCGGCTCCCCGGACGACTACCGCAGGCTGCTGAGCGAGCTCGACCAGTCCGCGCCATGGCGGCTCGTCCACCTGTGGAGCCTCGACGACGGCCCCGTCCACCACGCCTGCCACGACGTGCTGCGCCTCGCCCAGTCCTCCGGCTGGCTGCGGGCCGGCATCGCCGGGTACTGGCTCGTCACGCGGGGCGCGCAGACCGCCGTCGACACCGACCGCGTCCAGGCACCGGCCCACGGCGCCGTCTGGGGAATGGCCCGGGCGATGGCCCGTGAGCACCCCGGATGGGCCGTGCGGCTGGTCGACCTCGGCGCGGCGGACGGCGCCGACGCCCTGCTCGGCGAGCTCACCGAGGACGGGACGGAGGACCAGATCGCGCTGCGCTCCGGCACCCGGCTCGCCGCCCGGCTGGTGCGCCGGCCCTGGCGCCGGGAGAGCCGGCCGAGTCCGGTCGCGACCGGCCCCTCCCAGAACCTGCGGATGTCCGTCGAAGCACCGGGAGTTCTCGGCAAACTGGGCTTCGCCCCCGCCGAACGAACCGCACCCGGGCCCGCCGAGGTCGAGCTCCGGGTCGACCACGTGGGGCTCAACTACCGTGACGTACTCCTCGCGTTGGGCGCCCTGCCGGACTCCGCGGGAGCACCGCTCGGACTGGAGTGCAGCGCGACCGTGACCGCGGTCGGAGCCGAGGTCACCTCGGTCCGCGAGGGCGACGAGGTCGTCGCCGTCGTCGAGGGCGGCCTCGCCCAGTACGTACGGACGTCGGCGCACATGGTGGCGCGTCGTCCCGCCGGACTGTCGGCGGCGGAGGCCGCGACACTGCCCATCGCCCTGATCACCGCCTACCACGCGATGTTCGACGTCGCCGGACTGCGCGAGGGCGACCGGGTGCTCATCCACTCCGCCACCGGCGGGGTCGGCATGGCCGCGCTCCAGCTCGCGCGCTGGAAGAACCTGGAGATCTACGCCACCGCAGGCAGCCCCGAACGGCGGGCGCTGCTGCGCGCGATGGGCGTCCGGCACGTCGCCGACTCGCGCTCGCTCGCGTTCGCGGACATGGTGCGCGAGGCGACGCTGGGGGAGGGGGTGCACGCCGTCCTCAACACGCTCAGCGGGCAGGAGGCGATCTCGGCGAACCTGTCCCTGGTCGCCTCGCACGGCACCTACGTCGAGTTGACGAAGCGCGACCTCTACGCGGGCACCCCGATCGACCTGCGACCGTTGCTGCGCAATGTCTCCTTCTCCGTGGTGGACGTGGTGGAGATGCTCCAGCGCCGGCCGCGGATGGTCGGCGAGGTGCTGGCCAAGGCACTGCGACTGGTCGCGGCGGGTGAGCTCGGCCCCCTTCCGTACCGCGTCTTCCCGGCCGCCCGGGCAGCCGACGCCTACCGGGAGATGGCCGGAGCGCGGCACACCGGGAAGGTCCTCGTCGCCCTGGACGGCAGCGAGGAACAACCGCGGGCCGAAGGCCCCGGAGGACGACGCGCAAGGACGCCCGCCGCGAGCGGCGCCGAACACCCGCGGATCAGCCCCGACGCGACCTACCTCGTGAGCGGCGGACTGGGCGGCCTGGGACTGGAGGTGGCGCACTGGCTGGCCGACCGGGGAGCGCGGGAACTGCTCCTGCTCGGCCGGACCCCGCTCGCCGCGGACGGATCCCCCGACGTACGTCTGGAGGGCCTGCGAAGCCGCGGGGTCCGGGCCGACTACGAGGCGCTCGACGTGGCCGACGAGCCCGCCCTCCGCGACGTCGTCGCGCGACGCGCGTCCGCCGGACGGCCACCGGTCCGCGGTGTCGTCCACGCCGCCGGAGTGGTCCTGTTCAAGAGCCTCGACGAGACGACCCGCGAGGAGCTCACGGGCTCGCTGCGCCCCAAGGGGGACGGCGCGCTCGCGCTGCACAACGTGCTGGACGGAGCCGCCGACGGCACCTCGCTGGACTTCTTCGTCCTGTTCTCCTCCGGATCCTCCATCCTCGCCTCCCCGTTGCTGGGCGCGTACGCGGCAGGGAACGCCGCGCTCGACTCCTTCGCCCGGTGGCGCCGGCAGGCCGGACTGCACGCCCTGTCGGTCAACTGGGGCTTCTGGTCCGAGGCGGGCCTCGCGGCCAAGTTCGACCAGGAGCAGGGCCGTCCGCTGGCCCCGGCCGGCATCGCCACCTTCACCCCGGCGCAGGGACTGCGGATCCTGGAACGGCTGCTCGCCGAGGACGCGACCGAGGCCATGGTGATGCCGGCCGACTGGGAACGCTGGGCCACCACCTACCCGGAGGCGGCATCGGCCGCGCTCCTGACGGAGGTGCTCGGCCGCGAGGTACCCACCGCCGTGCCGACGCCGCCGCCCGCGGACCGGCACGCCCCCGTCGCGGCGACCGCACCGCACGCCGAACCCCAGCCCCGGCCCGGGCCCGAACCCGCCCCCGGCGGACGGGACATGGGCGAGTACCTGACCCGGAAGATCGCGGAAGTGCTGGGACTGCCCCTCGACCAGGTCAGCAGGAACCGCCCGCTGAACCGGCAGGGCATGGACTCGCTGATGGCGGTCGCGGTGCGCACCCGGGTGCAGGAGGAACTCGGCGTGACGATGTCGATGGCCAAGATGCTGGGCGGCCAGACCATCAGCGAACTCGCGGGCGAACTGGCGGCCGATGTGACGGCCGGTACGGGGTCGTGA	MPIAIVGIGCRFPGARGADEFWSLLRASRDVISEVPADRFDVDAFHEPGPVKPGKISTRYGGFLDHVDEFDAVFFGVAPKEAAHMDPQQRLLLETTYDALVDAGIAADTLAGSSTGVFVGQLTADYWDLLSRESDLDIYANTGTTRAVTSGRVSYAFDLRGPSLTLDTACSSALTAVHLACDSLRNGESSLALASGVNLVLQPEPSITFSQAGMLAPDGRCKFASPAADGFVRSDGIATVVLKRLDQAEADGDDIYAVVLGSAVTSDGEGSGYLLTPSVEGQERTLRSAYRNAGADPAAVGYVEAHGTGTAIGDRVELTALARVLGENRPAGEPCRVGSVKTNIGHTEATAGLAGLIKTALCLKHGRIPASLHADTLTDSVDWDELPLVVQREPVAWEARGPRLAGVSSFGISGTNAHVVLAEHTPAAPEAKETQPAPDAEDETGPVLLPLSTRGPAALRRAAADMADFLGPDGAGSAIPLRDIVATAATRRQHLDSRVAVVGGTHDQMAEALRAFHDGALPSGAGRAADDVEDKPVRTVFVFPGQGSQWVGMGRELLATSPAFRDALTRCDEAVRAETGWSVLDRIADDAPLTEIDVIQPTLWAMEVALAHLWRSWGVEPDAVVGHSMGEAAAACVSGALSVEDAAAVICRRSRLLRQVAGQGAMAFVELTAEEAEREIADHADRVSVAVINGPTSTVLAGDPGALEEILDRLKQRDVFGQPIKVDVASHSPQMDPLREQLLEELSFVRPRSGKVPLHSTVLDEVLDGSQLGTGYWALNLREPVRFGPVVQGLLNTGRTLFIEMSPHPVLVPAVLECLSLAGANAGVAVPSLRRDEPERATLLDAVATLYTAGVPVDWHGLGQEGSPVRLPKYPWQRGSHWYTPSRPVAMPLARGAAAPGHPLLGPRQTGGPDLVREGRLDLAGANAYLADHQVQGAALLPGTAYVEMMTAAAREACAPHRPALTELTCHRAMFLRPGEEPLVQVRITGAGSPDPRIEVRSSVDGEPMIVHATARILTDGPPRRPADDTLASRSAARERATDHWSGADFYADSARSGNIWGPAFQGITELWRRDGEALARVQTPPALPATGDAQIFHPALLDACAQVLSATVTGQDGAASEVFVLASMDRVSLYGSPQGPLWSHAVRTSRDDVSYVGDITVTDEDGTVLAELHGVRLRYLEREGVRPGDVRPRARRAGTPDDDRELSDWLYELDWRPAPRRAGGELPDGPWLVFADRHGIGTALAEQLTAAGRTCVRVSAGAGYRRLSDTAVELDPGSPDDYRRLLSELDQSAPWRLVHLWSLDDGPVHHACHDVLRLAQSSGWLRAGIAGYWLVTRGAQTAVDTDRVQAPAHGAVWGMARAMAREHPGWAVRLVDLGAADGADALLGELTEDGTEDQIALRSGTRLAARLVRRPWRRESRPSPVATGPSQNLRMSVEAPGVLGKLGFAPAERTAPGPAEVELRVDHVGLNYRDVLLALGALPDSAGAPLGLECSATVTAVGAEVTSVREGDEVVAVVEGGLAQYVRTSAHMVARRPAGLSAAEAATLPIALITAYHAMFDVAGLREGDRVLIHSATGGVGMAALQLARWKNLEIYATAGSPERRALLRAMGVRHVADSRSLAFADMVREATLGEGVHAVLNTLSGQEAISANLSLVASHGTYVELTKRDLYAGTPIDLRPLLRNVSFSVVDVVEMLQRRPRMVGEVLAKALRLVAAGELGPLPYRVFPAARAADAYREMAGARHTGKVLVALDGSEEQPRAEGPGGRRARTPAASGAEHPRISPDATYLVSGGLGGLGLEVAHWLADRGARELLLLGRTPLAADGSPDVRLEGLRSRGVRADYEALDVADEPALRDVVARRASAGRPPVRGVVHAAGVVLFKSLDETTREELTGSLRPKGDGALALHNVLDGAADGTSLDFFVLFSSGSSILASPLLGAYAAGNAALDSFARWRRQAGLHALSVNWGFWSEAGLAAKFDQEQGRPLAPAGIATFTPAQGLRILERLLAEDATEAMVMPADWERWATTYPEAASAALLTEVLGREVPTAVPTPPPADRHAPVAATAPHAEPQPRPGPEPAPGGRDMGEYLTRKIAEVLGLPLDQVSRNRPLNRQGMDSLMAVAVRTRVQEELGVTMSMAKMLGGQTISELAGELAADVTAGTGS	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	520.43	gnl|BL_ORD_ID|1968|hsp_num:0	1943			480	1248	isoniazid
BGC0001409.1|Dutomycin_31 # 36923 # 38005 # -1 # ID=1_31;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=8bp;gc_cont=0.714	BGC0001409.1|Dutomycin_31 	36923	38005	-	Loose	500	28.8758	Vibrio cholerae varG	22.99	3004289	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	Subclass B1 Vibrio cholerae varG beta-lactamase	GTGAGTCTGACCCGGACATTGAGGGGACGGTGCCGGGAGGCCTGCGTGCGAGTCGGCGACATCTACATCGATGCACTGGGGACATGGCTCCCCGAGCCCTACAGCGCGGAGCGCGCGGTACGCGAAGGGCTCTACGAAGCCGTGGACTTCGAGGAGAACGGACTGCTCGCGGCACGGGTCGCGGGCCCCGACGAGGCGCCGGCGGAGATGGCCGTCCGCGCGGTGCGGCAGCTCGCGGAGCGCCGCGGCTCGGATCTGTCCGACGTGGACCTCCTGGTGCACGCCGGTTCGTCTTGGCAGGGGCCGGAGGGCTGGCGGCCCGCCTCGTACATCCAACGCAAGACGGTGGGCGGCACCGGCCCCGCCTGGGAGCTCACCATGGGCTGCCTCGGCGGACTGACCGCCCTGGAGGTCGCGGTCGGCCACCTGCGCGGTGACGCGTCACGGCGCACGGTGCTCTTCACCTCCGCGGACAACTGGTCGTCCCCCGTGGTGGACCGCTGGAGGTCCTTCCCCGGCGTCATCCTCGGCGACGGCGCGTCGGCCCTCACCCTGGGCAGGGGGACGGGATTCGCCCGGCTGCTGTCGGTCAACACCGGCGGTGTCCCCGATCTGGAGGGCATGTACCGGGGCAGCGAGCCCTTGTTCCCCGGCACCTCCCTGCAACGCGCCCCGCTGGACTTCCGGTTGCGGGCGACGGCGTACAAGGAGACCGAGCAGGCCAGCTCCGAGGCGATGATGCTGTCCGCCAAGGTCCAGCTGGAACTCATCGACCGCAGCCTCGAAGAGGCCGGTATCGGCCGCTCCGACATCACGCGTGTCGCCTACGTCAACTACGCGCGGCTGGCGACCCAGATGTGGCTGCTCGATCCGCTCGGCATCCCGATGTCCACGTCCACCTGGGAGATCGGCCGGCACATCGGGCACATCGGCCCGAGCGACCAGCTCGTCTCCCTGGACCGGCTGCTGTCCCGCGGCGAACTCGGCCCCGGAGACCACGTCCTGCTCGCCGGGCTCGGCCCGGGTATGACCCTCGGCAGCGCCGTGCTGGAGATCGTCTCCCGGCCCTCCTGGCTCGACTGA	MSLTRTLRGRCREACVRVGDIYIDALGTWLPEPYSAERAVREGLYEAVDFEENGLLAARVAGPDEAPAEMAVRAVRQLAERRGSDLSDVDLLVHAGSSWQGPEGWRPASYIQRKTVGGTGPAWELTMGCLGGLTALEVAVGHLRGDASRRTVLFTSADNWSSPVVDRWRSFPGVILGDGASALTLGRGTGFARLLSVNTGGVPDLEGMYRGSEPLFPGTSLQRAPLDFRLRATAYKETEQASSEAMMLSAKVQLELIDRSLEEAGIGRSDITRVAYVNYARLATQMWLLDPLGIPMSTSTWEIGRHIGHIGPSDQLVSLDRLLSRGELGPGDHVLLAGLGPGMTLGSAVLEIVSRPSWLD	MFVSHLSFPHLIEERKMKLSTLALAPITAALLTFNASAKGHDHDNQRAIFFPGETVQDTVKVEVEPSATQSLKLGQKINNLYERQFDNSQATVQKLGKNTYWIGVNYYNATVVVNEDSVLLIDPLGDGRIDALFKGVQSITNKPITTIMYSHYHLDHLGGGNQLVDLIKKNYPKVDKIRVIASQTVADKINQHAEVGENGVKTPKVPAPNDIYDLTKPQTVQFGSMKIKMMAPKGSGHTPDNTMILIPSDRVLHFADMINPDQLPFYNFAGAEHFHGYEEDLQSLLSKPLSKQWDFINGGHGNIGSKQDVKDLLEYIADIRTEVGKQLEVAPYTPVLSDGNHFVWFKRWQDEITNNVHTALANKYGHMYGFDSGVVETHAAMILADMIDH	92.31	gnl|BL_ORD_ID|2428|hsp_num:0	2842			18	501	meropenem
BGC0001409.1|Dutomycin_32 # 38272 # 39108 # 1 # ID=1_32;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.708	BGC0001409.1|Dutomycin_32 	38272	39108	+	Loose	650	281.567	tetA(58)	53.26	3003980	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGCTGGGCCTGCTCGGTCCGAACGGGGCCGGCAAGACGACGGCCGTACGCATCCTCGCCACTCTGCTGCGTCCGGACGACGGTCAGGCCTTCATCCACGGGCACGATGTGGCGAAGGCCCCGGACCGGGTCCGCGACATCATCGGCCTGACGGGGCAGTACGCCTCCGTCGACGACACCCTGACCGGCGTCGAGAACCTGGTGTTCCTGGGCCGGCTGCTCGGCCGGTCGCGGGCCGACTCCCGGCGCACGGCGCTGAGTCTGCTGGAGCGCTTCGGTCTCACCGATGCCGGCGACCGCACGGCCAAGACGTACTCCGGAGGTATGCGCAGGCGTCTGGACCTGGCGGCCTGTCTGGTCGGCGACCCCAAGGTGATCTTCCTGGACGAGCCGACGACGGGCCTCGACCCCAACGCCCGCGACCAGCTGTGGGAGATCATCCGCGGGGAGGTGCGCCGGGGTGTGACCGTCCTGCTCACCACGCAGTACCTGGAGGAGGCGGACCAGCTCGCCGACGACATCGTGGTCATCGACCACGGCTCCGTCGTGGCTCGAGGCACGCCGGAGATCCTCAAGCGCGAGGTGGGCCGGCCCACGCTCCAGGTACGCCCCCTGGACGGCGCGCACCTGGACCGGGTGGCGGCCATCGTGAGCGAGGTGACCGGCGGCCATACGGTCGAAGGCCACGCCGTCACCTCCCGGGTGAGCGACACGGCGGCCCTGTACGCGGTCGTACGGCGGCTGGACGACGCCGGGATCGCGGTGACCGAACTGTCCATCCGCGAGCCGAGCCTCGACGAGGTGTTCAAGCAGCTGACGACGGGAGCACCGGTATGA	MLGLLGPNGAGKTTAVRILATLLRPDDGQAFIHGHDVAKAPDRVRDIIGLTGQYASVDDTLTGVENLVFLGRLLGRSRADSRRTALSLLERFGLTDAGDRTAKTYSGGMRRRLDLAACLVGDPKVIFLDEPTTGLDPNARDQLWEIIRGEVRRGVTVLLTTQYLEEADQLADDIVVIDHGSVVARGTPEILKREVGRPTLQVRPLDGAHLDRVAAIVSEVTGGHTVEGHAVTSRVSDTAALYAVVRRLDDAGIAVTELSIREPSLDEVFKQLTTGAPV	MEHAYKKKIEPKPGDLAVEAYGLIKTFGDNRAVDGVDLNVRTGTIYGVLGPNGAGKTTTIRMLATLLRPDAGSARIFGHDVQAESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGLGRKEARRKAEELLEEFGLSEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRSQMWDTIRRLVNTGSTVLLTTQYLEEADQLADRIAVIDYGRVVAEGTADELKMSVGTSSLHLTVEDSVDMDRACHTVEQVLGVHANVSPEAGKITAPMANAGLVTDLLIELRTAGIGLSEMSVQKPTLDEVFLTITGHGVKEDAAQESYESNDREVARV	81.05	gnl|BL_ORD_ID|2243|hsp_num:0	2517			132	960	tetracycline
BGC0001409.1|Dutomycin_33 # 39105 # 39911 # 1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=7bp;gc_cont=0.664	BGC0001409.1|Dutomycin_33 	39105	39911	+	Loose	500	201.83	tetB(58)	37.16	3003981	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACGACCATCGCCGAACCCACGGACCGGGTGGCGCGTCGCCGCGGACCGGCCGCGGCCGTGCAGCAGAGTGCCACGGTCGCCTGGCGGCAGCTGGTGCAGATCAAGCACAGTCCGGAGACACTCGTCGAGGTCGGCATCCAGCCGGTCATCTTCGTCTTCCTGTTCGCCTTCGTCCTCGCCGGTCAGATGGCCGGCTCACGTCACGCGTATCTGCAGTTCGTGGTCCCCGGGCTGATCGTGCAGAGCACCGTCCTGGTCACCGCGCGCACCGCGATCGGGATGAACACCGATGTGACGAAGGGGCTCTTCGACCGCTTCCGCAGCCTGCCGATCTCCCGTACCGCACCGCTGATCGGCAGGATCTTCGCGGACTACGTCATGCTCGTGTGGTCGGTGGTGCTGCTGCTGGCCTTCGGGATGCTGCTGAGCTTCCGGATCGAGACGAGCTGGGGTCAGCTGATCCCGATGTTCCTGCTGCTCCTGGTGTTCTCCTTCGCGCTGTCCTGGGCCTCGGTGCTCGCCGGGCTGCTGGCCAAGGATCCGGAGAACGTGCAGGCGCTGGCTTTCGGGATCATGCTGCCGCTGACTTTCATCAGCGACGCCTTCGTCCAGGTGGAGACCATGCCGGGGTGGCTCCAGGCGATCGTGAAACTCAACCCGGTGTCCATGCTGGCCGATTCGATCCGCGGTCTGCTGGTCGGCGGTCCGGTGGGCGAACCCGTGACGAAGACGCTCATCGCGTCGGCCGTCCTCTTCGTGGTGTTCGCCCCGCTGGCGCTGCGCGCCTATCACCGCGAGCGGTAA	MTTIAEPTDRVARRRGPAAAVQQSATVAWRQLVQIKHSPETLVEVGIQPVIFVFLFAFVLAGQMAGSRHAYLQFVVPGLIVQSTVLVTARTAIGMNTDVTKGLFDRFRSLPISRTAPLIGRIFADYVMLVWSVVLLLAFGMLLSFRIETSWGQLIPMFLLLLVFSFALSWASVLAGLLAKDPENVQALAFGIMLPLTFISDAFVQVETMPGWLQAIVKLNPVSMLADSIRGLLVGGPVGEPVTKTLIASAVLFVVFAPLALRAYHRER	MSSSMIQPGTERQLKNRTSLGQTVRNSLTMAYRGLLKLRRTPEQLFDVTFQPIIFTLMFTYIFGGAISGDVASYLPVIIPGILVQTVITTSVVTGVQLREDMDKGVFDRFKSLPIARIAPLAGALLADTIRYTIATVLTFTMGYIMGYRPEGGLGYVALAGLVVILCSWAISWIFAFCGVIARSASGVQGISMIVLFPLTFLSNAFVPVDTMPGWLQWFVNMNPISHLVTAVRDLTNAGTVGWDLTISLVGAAVIVAIFAPITVRAYMRRT	98.89	gnl|BL_ORD_ID|4708|hsp_num:0	2518			27	810	tetracycline
BGC0001409.1|Dutomycin_34 # 39924 # 41072 # 1 # ID=1_34;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=7bp;gc_cont=0.764	BGC0001409.1|Dutomycin_34 	39924	41072	+	Loose	700	39.6614	oleD	29.5	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGAGGGTGCTGATCGTCGCGCTGGTGCCGAGTCATCTGATGTCGATGGTGCCGGTCGCCTGGGCCCTGCGGGCGGCCGGGCACGAGGTCCTGGTCGCGGGCGGCGCGCCCGTGGCGGAGCGGGCGGCGGCCGCCGGGCTCTCGGCGGCCGTGGTGAGCGAGCCGCCGGGCCGGCGGGTCCGGCGCTCGGCGGCGCCGTCGGGGCTGCCCGGCGCGGGGCCGGACTGGACACTGCTTCAGGAACGCTGGCGGCAGCGGGTCGACGGCATCCTGGACGAGCATCTGGACGTCGCCCGTGACTGGCGGCCGGATCTGCTCCTGGTGGATCCGATCGAGTTCAGCGGTCTGATCGTGGCGGCCGCGCTGCGCGTCCCGGCCGTGGTGCACCGCTGGGGGCCCGACCGCATCAGTTCGCAGTCGATTCCGCGGGCCGTCGAGGCACTCGCCGAGGTGGCGGCCCAGCGCGGGGTCGACGGCGGTCCGGCGCTGCCCTCGATGGTGCTCGACCCGTGCCCGCCGAGTCTGCAGTGCACGGACGCGTCGGCCGCGCAGCCGGTGCGGTTCGTGCCGTTCAACGGGGCGGGTACGCCGCCCCGTTGGGCCCAGCGGCCGCGCTCGGGGCGCCGGCTGTGTGTGTCGTTCGGCGGTGAGACGCCGATGCTGACCCAGCCCGCGGTGTGGGACGCGCTGATCCGTGAACTGGCCGCCGTACCCGACCTGGAGTCGGTCGTCACCGCCGTGCCCAAGGACGCTGGCGCCCTGCCCGCCACCGTGCGCGCACCCGGGCAGGTGCCGCTGGACCTGTTCCTCGACGGCTGCGACGCGCTGCTGCACCACGGCGGCGCGGGCACCGCCCTGACCGGTCTGGCGTTCGGCGTCCCGCAGTTGATCGTCGCCCAGCCGAATCCCTCGTGGGCGGCGGTCGGCGAGCGGATCGCGGCGCGCGGCGCCGGTGTCGTGCTCGACCTGGACGCGGCCCTGCGCGAGGAGTCCACGGCGGGCCTGCGCGCGGCGGTCGAGGAGGTGCTGTCCTCCCCCGGTTACCGCTCCGCGGCCGAGGCCCTCGCCGACGAGATCCGCCGACTGCCCGCGCCGAGCGCGGTGGTGCCCCTGCTCACGGAGCTGGCGGCGACGCCGGTCGGCCGCTGA	MRVLIVALVPSHLMSMVPVAWALRAAGHEVLVAGGAPVAERAAAAGLSAAVVSEPPGRRVRRSAAPSGLPGAGPDWTLLQERWRQRVDGILDEHLDVARDWRPDLLLVDPIEFSGLIVAAALRVPAVVHRWGPDRISSQSIPRAVEALAEVAAQRGVDGGPALPSMVLDPCPPSLQCTDASAAQPVRFVPFNGAGTPPRWAQRPRSGRRLCVSFGGETPMLTQPAVWDALIRELAAVPDLESVVTAVPKDAGALPATVRAPGQVPLDLFLDGCDALLHHGGAGTALTGLAFGVPQLIVAQPNPSWAAVGERIAARGAGVVLDLDAALREESTAGLRAAVEEVLSSPGYRSAAEALADEIRRLPAPSAVVPLLTELAATPVGR	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	92.05	gnl|BL_ORD_ID|1253|hsp_num:0	1367			675	1068	erythromycin; tylosin
BGC0001409.1|Dutomycin_35 # 41103 # 44297 # -1 # ID=1_35;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.746	BGC0001409.1|Dutomycin_35 	41103	44297	-	Loose	400	29.6462	vanR gene in vanO cluster	32.26	3002930	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGCCAGCCGGTGCCGCCATCAGTGTTCTCGGACCGCTGCGGGTAAGCGCCCCGGACGGGGCCGCCGACGTGCGCGGAGCCCGGCTGCAGACCCTCCTCGCGATCCTGGCGCTCGCCGCGGGCCGGGAGGTGGCCCGCTCGGATCTCCTCGAAGCGCTGTGGGACGACACCCTGCCGTCCGCCCCGGACAACGCGCTCCAGGCCCTGATCTCCCGGCTCCGGCGGGCCCTGCCCGGACTCGTCGTCGAGTCCAGCCCCACCGGCTACCGGCTGGTCGTCGGGCGTGACGAGGTCGACGCGCTGCGCTTCGAATCACTCGTCCTGGCCGTCGGTGCCGCGCGCGGCGACCACGAGCGGCGCGCCGCACTGCTGGGCGACGCCCTGGCACTGTGGCGCGGTCCGGCCCTGGCCGGACTGACGCCCACACGGGTCGTCCGCGCCCACGCCACCCGTCTGGAAGAACTCAGACGCCGCGCCCGGGAGGACCGCGTCGACGCCGAGATCGCGGGCGGCGGCGGCGCCGGACTCGTCGCCGAACTCGCGGGACTTGTCTCGGAGGACCCGTTCCGGGAGAAGTTACGCGTCCAGCTGATGCGGGCGCTGCAGGCCGCGGGCCGGCAGACCGAGGCCCTCGCCGTCTACGAGGAGGCGAGGGCCCAGCTCGTCGAGGCGTACGGAATCGACCCCTCGGCCGAACTCCACCAGGCGTATCTGGACGTCCTGCGCGGTGAAGGACCCCCGTCGAACCGACGGCCCGTCCGGGAGCCGCGGTTGCCCGTGCCGCTCACCGAACTGATCGGCAGGGAAGCCGATGTCGAACGGGTCCAGGAACTTCTGGCCCGCGCCCGGCTGGTCACCGTCGTCGGCCCCGGCGGCGTCGGCAAGACCCGGGTCGCCGTGGAGTCGGCCCGCCGTGCCGACGCCCGCGGCGCCGACCGCGTCTACCTGGTCGAACTCGCCGCCGTCACCGACCCGGTGAATGTACCCCGCACCATCCTGGACGCCACGGGCGCCGGCGAGGGCGGACTGCTCTCCGCCCCCGGATTCGAGACCGCGCGAGGCGCCGTGCTGCGCCGGCTGACGAGCCTGCTGGCCGAGGAGCGCGTACTGCTCGTCCTCGACAACTGCGAGCACCTCGCCGACATGGTCGCCGAGACCGCCGCGGCCCTGCTGGCCCGCTGCCCCAACCTCCGTGTCCTGGCGGCCAGTCGGCAGCCCCTCGGCGTCAACGGCGAACGGCTGCACCACCTTTCCGGGCTGGCGTTGCCGCAGCGGACCGCCGACGCCCCCGACAGCCCCGCGGTACGGCTCTTCGTCGACCGCGCCACCGCCGTGCGCCCCGGCTTCGCGCTGGACGGGCACACCGCGGAGCCGGTCGTCGCGATCTGCCGCGCGCTGGACGGACTGCCACTGGCCCTCGAACTCGCCGCCGCCCGGCTGCTGTCCCTCTCCGTCGGGCAGATCCGTGACCGCCTCGACGACCGGTTCCGGCTCCTGAGGCCCGAAGGGCATCCCGCCGACGGACGGCAACGCACCCTGCGGGCGGTGATGGACTGGAGCTGGGACCTGCTGGACGACACCGAGCGCACCCTGGCCCGGCGGCTCGCCGTCTTCGCGGGCCGTGTCGACCTCCCGCTGATCGAGCGGGTCTGCGCCGGCGACGGACTCCGCGGCGACGACCTCGACACCCCGCTGTCCTCGCTCGTCGCCAAGTCCATCGTGCAGACGGAGGAGACCGACGGGCGCATCGGCTACCGCATGCCCGAGACCGTACGCCTCTACGCCGCCGAGCAGCTCGCCGCGGCGGGCGACGAGGACCGGGCCAGACTGCGGCACGCCCAGGCGCTCCTGTCGATCGCCGAGACCGCCGAGCCGAAGCTGCGCCGGATCGGTCAGCCCGCCGAACTCGCGGCGCTGACCGGCCTGTTGGACGACTTCCACGCGGCCCTTCGGTGGTCCGTCGACGCCGGGCAGCCCGAACTGCCGGTGCGCCTGGTCGCCGCGCTGGAATGGTTCTGGCTGCTGAGCGGGCGGCGCGCGGAGGGCACCGAATGGACGCGCCGCGCGCTCGCCGTGCCGTGCGGGACCCGGTCCAGGGAGCGGGCGATCGTCTGCACCATCGGGGGACTTCAGCACGGAGCCCTGCTCGGGCAGGAGGAAGGCGTCGAGTACCTCTTCGAGGCACTGGCCCTGATCCAGGACCTGGCGGAGGCGGAAAGAGACCACCCGGTGCTGGTGGCCGCCTCCGTCCTGGGTTCCCTCGCCTCAGGGACGCCGGAACTGGTCAGCGAAGTGCTGCGTGGGCTCACCGGCCACCGGGACCCCTGGATCGGCTCGTTCGCCCGGATGCTCGGCGCCCGGATGCTCGCCAACGCCGGACAGCCGCACGCCGCACGGGACGAACTCCTCGCCGCACTGGACGGGTTCCGTACGCTCGGCGAGCGCCTCGGACTGACGTACACGCTCACCGCGCTGGCCGAGTCCGAGAGCGCCCGCGGCGACCATGTCGGTGCGATGAGCGCCCTCGACGAGGCACTGCGCGCGGTCACCGAGCTGGGGGTCGCCGAGGACCGGCCGATGCTCATGGTCCGCCTCGCGGTCGAGCACGCCAGGACCGGTAGCCCCGACCGGGCCGAAGCGACTCTGGAAGAGGCCGCGGCGGAGGCGTCCCGGCTGGGCCTCGGCGAGGTGCTGGGCGTCGCCCACCACGCGCTGGGCGATCTGCGCCGCACCGCGGGTCGGCCGGTCGAGGCCCGTCGGCTGCTCGACCGGGCCCTCGCCGAGGTCATGGCCCACGGTCAGGGTGTCGGCCACCGTCCCGCCGTCCTCACCAGCCAGGGACACCTGGCCGTCGCCGAAGGCCGGCTGCCCGCCGCGCTGGAGGCCTGCACGACCGCGCTGGACCTCGCCCGACAGGTCGAGGACGCCCAGCTGACGGCCCGTGTACTGGTCCTCGCCGCGGACATCGCCCTCGCCCAGGCCGAGCCCAAGTCCGCGGCGGTCCTCCTGCACACCGCCGCGGACGTGCGGGGCCAGCAGCTCGACGCCGACCCCGATGTCCACCGGGTCGCCCGGGCGACCCGGCTGGCGCTCGGGGACGACCGGTACGGGGCCGCGCGGGCCGTGCCCACGGACGAGACCGAGGCACTGATCGCGGGCCTCAGCGGGCGGCTGGCACCTCCCTCGGCACGGTGA	MPAGAAISVLGPLRVSAPDGAADVRGARLQTLLAILALAAGREVARSDLLEALWDDTLPSAPDNALQALISRLRRALPGLVVESSPTGYRLVVGRDEVDALRFESLVLAVGAARGDHERRAALLGDALALWRGPALAGLTPTRVVRAHATRLEELRRRAREDRVDAEIAGGGGAGLVAELAGLVSEDPFREKLRVQLMRALQAAGRQTEALAVYEEARAQLVEAYGIDPSAELHQAYLDVLRGEGPPSNRRPVREPRLPVPLTELIGREADVERVQELLARARLVTVVGPGGVGKTRVAVESARRADARGADRVYLVELAAVTDPVNVPRTILDATGAGEGGLLSAPGFETARGAVLRRLTSLLAEERVLLVLDNCEHLADMVAETAAALLARCPNLRVLAASRQPLGVNGERLHHLSGLALPQRTADAPDSPAVRLFVDRATAVRPGFALDGHTAEPVVAICRALDGLPLALELAAARLLSLSVGQIRDRLDDRFRLLRPEGHPADGRQRTLRAVMDWSWDLLDDTERTLARRLAVFAGRVDLPLIERVCAGDGLRGDDLDTPLSSLVAKSIVQTEETDGRIGYRMPETVRLYAAEQLAAAGDEDRARLRHAQALLSIAETAEPKLRRIGQPAELAALTGLLDDFHAALRWSVDAGQPELPVRLVAALEWFWLLSGRRAEGTEWTRRALAVPCGTRSRERAIVCTIGGLQHGALLGQEEGVEYLFEALALIQDLAEAERDHPVLVAASVLGSLASGTPELVSEVLRGLTGHRDPWIGSFARMLGARMLANAGQPHAARDELLAALDGFRTLGERLGLTYTLTALAESESARGDHVGAMSALDEALRAVTELGVAEDRPMLMVRLAVEHARTGSPDRAEATLEEAAAEASRLGLGEVLGVAHHALGDLRRTAGRPVEARRLLDRALAEVMAHGQGVGHRPAVLTSQGHLAVAEGRLPAALEACTTALDLARQVEDAQLTARVLVLAADIALAQAEPKSAAVLLHTAADVRGQQLDADPDVHRVARATRLALGDDRYGAARAVPTDETEALIAGLSGRLAPPSAR	MASMRVLVVEDERFMAEAIRDGLRLEAIAADIAGDGDTALDLLGVNAYDIAVLDRDIPGPSGDEIAQRIVASGGGIPILMLTAADRMDDKASGFELGADDYLTKPFELQELVLRLRALDRRRAHSRPPVREIAGLQLDPFRREVYRDGRYVALTRKQFAVLEVLVAAEGGVISAEELLERAWDENADPFTNAVRITVSTLRKRLGEPWLIATVPGVGYRIDTEPDARGGGDGG	456.65	gnl|BL_ORD_ID|4742|hsp_num:0	1689			477	660	vancomycin
BGC0001409.1|Dutomycin_36 # 44357 # 45589 # -1 # ID=1_36;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=5bp;gc_cont=0.680	BGC0001409.1|Dutomycin_36 	44357	45589	-	Loose	1750	26.9498	amrB	32.61	3002983	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCATCAAAGAGTGCCGCATCTGCGGCAACCGCACCCTGCTGCCGATACTCGACCTGGGGGCGCAGGCCCTCACCGGCATCTTCCCGCGCACCCGCGACGAGGAAGTCCCCGCCGTGCCCCTCGAACTCGTCCGCTGCTCGCCCGACGGCTGCGGCCTCGTCCAGCTGCGGCACACCGCCGACTTCGGGTTGATGTACGGCGAGGGGTACGGATACCGCTCCGGGCTCGGCGAGTTCATGATCCGCCACCTCGGGAGCAAGGCCGCCCTGCTCACCGAACTCGCCGGCCTCGGCCGTGACGACCTCGTCCTCGACATCGGCAGCAACGACTCCACCCTGCTGCGTGCCTACCCGGCGGACGGTCCCACCCTGGTGGGCATCGACCCGACGGGCGAGAACTTCCGCGAGTACTACCCCGAACACGTCACGCTGATCCCGGAGTTCTTCTCCAGGGAGGCCTTCGCCGGACACTTCGGCAGCCGCAAGGCCAAGGTCGTCACCTCCATCGCCATGTTCTACGACCTGCCGCGCCCCCTCGACTTCATGCGGGACGTCCACGACGTCCTCGCCGACGACGGAGTGTGGCTGCTGGAACAGAGCTACATGCCGGCCATGCTCGAAGCCACCGCGTACGACGTCGTGTGCCACGAACACCTCGAGTACTACGCCCTGCGGCAGATCGAGTGGATGGCCGAACGCACCGGACTGACCGTCATCCGCGCCGAGTTGAACGAGGTGTACGGCGGCAGCCTCTGCGTCGTCCTGGCCAAGAACCCCGAACGGCACCGCGTCGACGAGGCCGGGATCGCCGCCATCCGCGCCCGCGAGGCCGCGCTCGGACTGGACACCATGGCTCCGTTCGAAGCCTTCGCGCACCGGGCGGTGGAATACCGCGACGGGCTGCGCGACTTCCTCGACACCTCCCGCGCGGCAGGCAAGTTGACCCTCGGATACGGGGCTTCCACCAAGGGCAACGTGATCCTGCAGTACTGCGGGATCACCGAACGGGACCTGCCGTGCATCGGCGAGGTCAACAAGGACAAGGACGGCTGCTTCACCCCCGGCACCGGTATCCCCATCGTCACCGAGGCCGAGGCCAAGTCGCGCCGCCCCGACCAACTGCTCGTACTGCCGTGGATCTACCGGGACGGCTTCGTCGAGCGGGAGCAGGCCTACCGGGAGAGCGGCGGCAAGCTGGTCTTCCCGCTGCCCGAGCTCACCATCGTGTGA	MTIKECRICGNRTLLPILDLGAQALTGIFPRTRDEEVPAVPLELVRCSPDGCGLVQLRHTADFGLMYGEGYGYRSGLGEFMIRHLGSKAALLTELAGLGRDDLVLDIGSNDSTLLRAYPADGPTLVGIDPTGENFREYYPEHVTLIPEFFSREAFAGHFGSRKAKVVTSIAMFYDLPRPLDFMRDVHDVLADDGVWLLEQSYMPAMLEATAYDVVCHEHLEYYALRQIEWMAERTGLTVIRAELNEVYGGSLCVVLAKNPERHRVDEAGIAAIRAREAALGLDTMAPFEAFAHRAVEYRDGLRDFLDTSRAAGKLTLGYGASTKGNVILQYCGITERDLPCIGEVNKDKDGCFTPGTGIPIVTEAEAKSRRPDQLLVLPWIYRDGFVEREQAYRESGGKLVFPLPELTIV	MARFFIDRPVFAWVISLFIMLGGIFAIRALPVAQYPDIAPPVVSLYATYPGASAQVVEESVTAVIEREMNGVPGLLYTSATSSAGQASLSLTFKQGVSADLAAVDVQNRLKIVEARLPEPVRRDGISIEKAADNAQIIVSLTSEDGRLSGVELGEYASANVLQALRRVEGVGKVQFWGAEYAMRIWPDPVKMAALGLTASDIASAVRAHNARVTIGDVGRSAVPDSAPIAATVLADAPLTTPDAFGAIALRARADGSTLYLRDVARIEFGGNDYNYPSFVNGKTATGMGIKLAPGSNAVATEKRVRATMEELAKFFPPGVKYQIPYETASFVRVSMSKVVTTLVEAGVLVFAVMFLFMQNFRATLIPTLVVPVALLGTFGAMLAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMVEEKLPPYEATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFAFALAVSIGFSAFLALSLTPALCATLLKPVADDHHEKDGFFGWFNRFVARSTHRYTRRVGRVLERPLRWLVVYGALTAAAALLITKLPAAFLPDEDQGNFMVMVIRPQGTPLAETMQSVRRVEEYVRTHSPSAYTFALGGYNLYGEGPNGGMIFVTMKDWKERKRARDQVQAIIAEINAHFAGTPNTMVFAINMPALPDLGLTGGFDFRLQDRGGLGYGAFVAAREKLLAEGRKDPVLTDLMFAGTQDAPQLKLDIDRAKASALGVSMEEINATLAVMFGSDYIGDFMHGSQVRRVIVQADGRHRLDAADVTKLRVRNAKGEMVPLAAFATLHWTMGPPQLTRYNGFPSFTINGAASAGHSSGEAMAAIERIASTLPAGTGYAWSGQSYEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVPLGVIGAVAGVTLRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLADAALEAARLRLRPIVMTSLAFGVGVLPLAFATGAASGAQIAIGTGVLGGVISATLFAIFLVPLFFVCVGRVFDVVPRRRGGAQAALEAK	39.31	gnl|BL_ORD_ID|428|hsp_num:0	476			2268	2397	
BGC0001409.1|Dutomycin_37 # 45586 # 46566 # -1 # ID=1_37;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=6bp;gc_cont=0.719	BGC0001409.1|Dutomycin_37 	45586	46566	-	Loose	500	27.7202	L1 beta-lactamase	26.96	3000582	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	L1 family beta-lactamase	GTGCGCATCGCCGTCACCGGATCGATCGCGACCGACCATCTCATGACCTTTCCCGGACGCTTCGTCGAGCAGCTCATGAGCGACCACCTGGAGAAGGTGTCGTTGTCGTTCCTCGCCGACACACTGGAGATCAGGCGCGGTGGAGTGGCCGCCAACATCGCCGTGGGCCTCGGACGGCTCGGGCTCACCCCGGTCCTGGTGGGCTCGGCCGGCGTCGACTTCGCCGAGTACCGCGACTGGCTGCGCGCCAACGGCGTCGACACCGAGTCGGTGCGGGTGAGCGCGACCCGGCACACGGCCCGCTTCGTGTGCACCACCGACGCCGACCAGAACCAGATCGCCACCTTCTACGCCGGGGCGATGGCGGAGGCACGCGAGATCGACCTGGCGAGCGTCGCCGGACGCGTCGGCGGGCTCGGCCTGGTGATGGTCGGACCCGACGATCCCGAGGCGATGCTCCGGCACACCGACGCCTGCCGGGCGCTCGGCCCGGACTTCGCGGCCGACCCCTCGCAGCAACTCGCCCGGCTGGGGCGGGAGGAGACCCGGCGCCTCGTCGACGGGGCCCGCTTCCTGTTCACCAACGCCTATGAGGCGGCCCTGCTCCAGGAGCGGACCGGCTGGAACACCCCTGAAATCCTTGAGCGGGTGGGCAGTTGGATCGTCACGCACGGCGCGGAGGGTGTGACCGTCTCCCGTGCCGGCCGAGCGGAGCTGCGGATCCCCGCCGTCGAGGCGGCCGGGATCGTGGACCCGACCGGCGCCGGAGACGGCTTCCGCGCCGGCTTCCTCGCGGGCACCTCCTGGGGTTGGCCGCACGAGCGGGCCGTCCAACTCGGCTGCGCGCTGGCGACCTTGGTGCTCGAGTCCCTCGGCACGCAGGAGTACAAGCTGTCCGCCGCCGATCTGCACCTGAGGATCGAGGAGGCCTACGGGCCCGCGGCGGCCGCCGAGATCACCCACGACCTGGAGAGGCGATGA	MRIAVTGSIATDHLMTFPGRFVEQLMSDHLEKVSLSFLADTLEIRRGGVAANIAVGLGRLGLTPVLVGSAGVDFAEYRDWLRANGVDTESVRVSATRHTARFVCTTDADQNQIATFYAGAMAEAREIDLASVAGRVGGLGLVMVGPDDPEAMLRHTDACRALGPDFAADPSQQLARLGREETRRLVDGARFLFTNAYEAALLQERTGWNTPEILERVGSWIVTHGAEGVTVSRAGRAELRIPAVEAAGIVDPTGAGDGFRAGFLAGTSWGWPHERAVQLGCALATLVLESLGTQEYKLSAADLHLRIEEAYGPAAAAEITHDLERR	MRSTLLAFALSSLALAATLFTFDGAAADASLPQLQAYTVDPSWLQTMAPLQIADHTWQIGTHDLTALLVQTADGLVLIDGGMPQMASYLLTNMKARGTNTGPLRMVLLSHAHTDHAGPVAEIKRRTGAQVVVNAETAVLLARGGSDDLHFGDEITFPPVNADRIVMDREVVKLGGIAFTAHFMPGHTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLQGNARYPRLVEDYRRSFATVRGLPCDLLLTPHPGASNWNYAAGSNASEKVLSCKAYADAAEKKFDAQLAKETAGAR	110.51	gnl|BL_ORD_ID|1480|hsp_num:0	1619			360	696	
BGC0001409.1|Dutomycin_38 # 46604 # 47767 # -1 # ID=1_38;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=4bp;gc_cont=0.695	BGC0001409.1|Dutomycin_38 	46604	47767	-	Loose	250	25.409	arr-8	46.88	3002853	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin ADP-ribosyltransferase (Arr)	ATGTCCCGCCGTCTGTTCACCTCGGAGTCCGTCACCGAGGGCCATCCCGACAAGATCGCCGACCAGATCAGCGACACGATTCTGGACGCGCTGCTGAAGGAGGACCCCGCCTCGCGCGTGGCCGTGGAGACCTTGATCACGACCGGTCTGGTGCATGTGGCCGGGGAGGTCTCCACCCGGGCGTACGCGCCGATCGCGCAGCTGGTGCGGGAGAAGATCCTCGACATCGGCTACGACTCCTCGAAGAAGGGCTTCGACGGCTCCTCCTGCGGGGTGTCGGTGTCCATCGGTTCGCAGTCCCCGGACATCGCGCAGGGGGTGGACACCGGCGGCGCGGGCGATCAGGGGCTGATGTTCGGCTACGCGTGCGACGACACACCGGAGTTGATGCCGCTGCCCATCCAGCTCGCCCACCGGCTGTCGCGCCGGCTGTCCCAGGTGCGGAAGAACGGCGCGATCCCGTATCTGCGGCCGGACGGCAAGACGCAGGTCACCATCGAGTACGACGGTGAGCGCGCGGTGCGTCTGGACACGGTCGTCGTCTCCTCGCAGCACGCCGCGGACATCGATCTGGAGACGCTGCTGGCCCCCGACATCCGTGAGTTCGTCGTGGAACCCGAACTGAGGGCCCTCCTCGACGAGGGCATCAAGCTGGACATCGAGGGCTACCGGCTGCTGGTGAACCCGACCGGGCGCTTCGAGATCGGCGGCCCGATGGGCGACGCCGGGCTGACCGGCCGGAAGATCATCATCGACACGTACGGGGGCTACGCCCGGCACGGCGGTGGCGCGTTCTCCGGCAAGGACCCCTCGAAGGTGGACCGTTCGGCGGCGTACGCGATGCGCTGGGTGGCGAAGAACGTCGTCGCCGCGGGGCTCGCCCGGCGGTGCGAGGTCCAGGTCGCCTACGCCATCGGCAGGGCGGAGCCGGTCGGTCTGTTCGTGGAGACCTTCGGTACCGCGACCGTCGACGCGCCGAGGATCGAGGACGCGATCACCGAGGTCTTCGACCTGCGCCCGGCGGCCATCATCCGCGACCTCGATCTGCTGCGCCCGATCTACGCGCAGACCGCCGCGTACGGCCATTTCGGGCGTGAGCTGCCCGACTTCACCTGGGAGCGCACCGACCGCGTCGACGCGCTGCGCCGAGCCGCCGGTCTCTGA	MSRRLFTSESVTEGHPDKIADQISDTILDALLKEDPASRVAVETLITTGLVHVAGEVSTRAYAPIAQLVREKILDIGYDSSKKGFDGSSCGVSVSIGSQSPDIAQGVDTGGAGDQGLMFGYACDDTPELMPLPIQLAHRLSRRLSQVRKNGAIPYLRPDGKTQVTIEYDGERAVRLDTVVVSSQHAADIDLETLLAPDIREFVVEPELRALLDEGIKLDIEGYRLLVNPTGRFEIGGPMGDAGLTGRKIIIDTYGGYARHGGGAFSGKDPSKVDRSAAYAMRWVAKNVVAAGLARRCEVQVAYAIGRAEPVGLFVETFGTATVDAPRIEDAITEVFDLRPAAIIRDLDLLRPIYAQTAAYGHFGRELPDFTWERTDRVDALRRAAGL	MIKDWIPTTHENCKKMQGPFYHGTKAKLSVGELLTTGFNTHFEEGRTLKHVYFSAMLEPAIWGAELAVSLSGLDGRGYIYLVEPTGPFEDDPNLTNKKFPGNPTMSYRTSEPLQIVGVVEEWEGHSAEALKAMLDSLENLERNGLHVIYD	258.00	gnl|BL_ORD_ID|115|hsp_num:0	133			216	297	rifampin; rifaximin; rifabutin; rifapentine
BGC0001409.1|Dutomycin_39 # 47913 # 49469 # -1 # ID=1_39;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.698	BGC0001409.1|Dutomycin_39 	47913	49469	-	Loose	500	29.261	APH(3')-IIIa	25.81	3002647	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	GTGAGCGGGCGCGTCTCCCGGCGCTCCCTGCTGCTCGGCACCGGAGCCGCCGCGCTGACCATCGGCGGATCGGCCGTGCTGGCCTTCGGCTTCCGCGGTACGACATCGACCGGCACCCTGCTGCGCAGCCAGGTCCCGCTGCCCGAGGCGTTCCGGAAGCCGCTGACGGTGCCGCCGGTGCTGAAGCCCACCAGCTCGGCCGGCGCCACGGACACGTACGAGATCACCCAGCGCGAGGCGACCGCCGAGATCATCGACGGCCTGCGCACCCCGATCTGGGGGTACGACGGCATCTTCCCCGGCCCGACCCTGGTCACCCGGCGCGGCCGCAGAACCGTCGTGAGTCACCGCAACGAACTCCCCGTGCCCACCGTCGTCCACCTGCACGGCGGCAGGAACGCCCAGCGCCACGACGGCTACCCCACTGACCAGATCCTGCCGACGAGCGGGGCGCACATGAGCGCGCACCACGGCGGCGGCGACCTCAGCCACGGCGCGCGCACCTACGAGTACGACACCGACCAGCGCGCGGCCACCCTCTGGTACCACGACCACCGGATGGACTTCACCGGCCCGAGCGTGTGGCGCGGCCTCGCCGGGCTGCACCTGATCACCGACGACGAGGAGCGGTCACTGCCGCTCCCGGACGGCGACCGCGATCTGCCGCTCGTCATCATGGACCGGTCCTTCGCGGCCGACGGCAGCCTGCGCTATCCCAGCGTCGACAAGGACCTGGACAAGACGCCGGGGGTGACCTCCGGCTACGAGGCGGGCGTCCTCGGCGATGTCGTCCTGGTGAACGGAACTCCCTGGCCGTACAAGGAAGTCGACGCCGTCCGCCACCGACTGCGCCTGCTCAACGCCTCCAATGCGCGCCGCTACCGGCTGCGCCTCGACCCGGCCCCGGACGGCGTGCACGAGCCGTTCGTGCAGGTGGCCTCCGACGGGGGGCTCCTCGCCCGGCCGTTGACCCATCCGTACCTCGATCTCGCCTCGGCCGAACGGCAGGAGGTCGTCGTCGACTTCTCGCGCTACCGCGTGGGCCAGAAGGTGCGGCTGGTGAACGACTTCGGCGAGGGATCCACACGCCAGGTGATGGAGTTCCGTATCGCACGCAAGGCCAAGGACGACAGCCACGTGCCGCGCAGGCTCTCGGTGATCGAGCCGCTGGATCCCGGACGGGCCGTCAGGGAACGGGACATGGTCTTCCAGTCCAAGTCGATCGGGGACCACCACGGCTGGACCATCAACGGCGAACCCTTCTCCGTGGACCATGTGCACGCGGCGCCACGGCTCGGCGACATCGAGATCTGGAACCTGTACGCGGACTTCCACCATCCGGTCCATCTGCACCTGGTGCACTTCCAGGTACTCAACCGCGGCACCAAGGAACCCGGGCGGTTCGACCACGGCTGGAAGGACACCCTGGACCTGCGGCCCGCCGAACAGGCCCGGATCATCGCGCGGTTCGACGGCCACCGCGGCAAGTACGTCTTCCACTGCCACAACCTGGAGCACGAGGACATGATGATGATGGGCAACTTCGAGGTCCGCTGA	MSGRVSRRSLLLGTGAAALTIGGSAVLAFGFRGTTSTGTLLRSQVPLPEAFRKPLTVPPVLKPTSSAGATDTYEITQREATAEIIDGLRTPIWGYDGIFPGPTLVTRRGRRTVVSHRNELPVPTVVHLHGGRNAQRHDGYPTDQILPTSGAHMSAHHGGGDLSHGARTYEYDTDQRAATLWYHDHRMDFTGPSVWRGLAGLHLITDDEERSLPLPDGDRDLPLVIMDRSFAADGSLRYPSVDKDLDKTPGVTSGYEAGVLGDVVLVNGTPWPYKEVDAVRHRLRLLNASNARRYRLRLDPAPDGVHEPFVQVASDGGLLARPLTHPYLDLASAERQEVVVDFSRYRVGQKVRLVNDFGEGSTRQVMEFRIARKAKDDSHVPRRLSVIEPLDPGRAVRERDMVFQSKSIGDHHGWTINGEPFSVDHVHAAPRLGDIEIWNLYADFHHPVHLHLVHFQVLNRGTKEPGRFDHGWKDTLDLRPAEQARIIARFDGHRGKYVFHCHNLEHEDMMMMGNFEVR	MAKMRISPELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRADKWYDIAFCVRSIREDIGEEQYVELFFDLLGIKPDWEKIKYYILLDELF	196.21	gnl|BL_ORD_ID|1227|hsp_num:0	1332			138	306	neomycin; amikacin; ribostamycin; butirosin; kanamycin A; isepamicin; gentamicin B; paromomycin; lividomycin; gentamicin
BGC0001409.1|Dutomycin_40 # 49466 # 49915 # -1 # ID=1_40;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.709	BGC0001409.1|Dutomycin_40 	49466	49915	-	Loose	400	23.483	aadA27	39.13	3004682	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGGGCGCGGAAGTGGCGGACGGGAAGACCACGCTGTCGGCGACGGACGGACGGGCCCGCAGAAGGCGGGCGTACGGGCGTGGATACGCGGTGCTGATGTACACCGTGGCCCTGGTCTACTTCGGGCAGGCCGTCCTGGCCGGCCAGTTCATGTCGGGCAGCTACGACGCGCTGCGCTGGCATCAGTACGGCGCGACCCTCACGGACGCACTTCTGTTCTGCGCGCTCGTCACGGGCGCACTGCTGCGCTGGCACGGCAAGGGCAAACTGTGGCCGTTCCTGGCGGCGCTCACCCTGCTGCTGGCCAATCAGGCCCAGAACGGCGCGGGGGCCGCCCGGCTGCTGTCCCTGCACATACCACTCGGCGTCGCGATGATCGCGGGCGCGTTCCTGGTCGCCCTGCGGGTACGGCACGCCGGTGAGCCCGCCGACACCGGGACCTCCGCGTGA	MGAEVADGKTTLSATDGRARRRRAYGRGYAVLMYTVALVYFGQAVLAGQFMSGSYDALRWHQYGATLTDALLFCALVTGALLRWHGKGKLWPFLAALTLLLANQAQNGAGAARLLSLHIPLGVAMIAGAFLVALRVRHAGEPADTGTSA	MSETLQLEQLTESLQQLLGESLFAIYLYGSAVDGGLGPESDLDVLVVVNQALTLHQRQQLAETLLKISYPIGAAQRALEVTIVLKEQILSGSYPLSYELQFGEWLREELNQGALLRAHTDPDLSILLKKAQMHHRSLLGPSLTQWSTAIPEQHLWQAMADTYPSIVAHWDEDADERNQILALCRIYFSLITNEIVPKDQAAHWVIAQLPSLHQPILQRMIQEYKGEIRKQNWQQQHQALGPVVDFLSSKIDEQFNKKSSLIK	56.87	gnl|BL_ORD_ID|2241|hsp_num:0	3381			246	369	spectinomycin; streptomycin
BGC0001409.1|Dutomycin_41 # 50019 # 50951 # 1 # ID=1_41;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=7bp;gc_cont=0.706	BGC0001409.1|Dutomycin_41 	50019	50951	+	Loose	600	45.4394	EstT	29.57	3007459	protein homolog model	n/a	n/a	macrolide antibiotic; glycylcycline; tetracycline antibiotic	antibiotic inactivation	macrolide esterase	ATGGGCAAACACGAGTCCGTTCGTGAACAGGCAGGTGTCGCGCGGTCGACGACCGTCCTGGTTTCCTGCGCGCGGCTGCACACGGAACGTGTCGGGCAGGGCCCCGCCCTGGTACTGGTACCGGGCGGCGGTGGCGACGCGGGCATGTTCGAGGACGTCGTGCCGCTGCTCGCCGAGCGGTTCACGGTGATCACCTACGACCGGCGCGGCAATTCACGCAGCCCGCTCGCCGATCCGGCGGCCCGCATCGACGTGCCCCAGCAGGCGGACGACGTGATCGCGATCCTCGACCACTACGGCATCGACCAGGCGTACGTCTTCGGCAACAGCGGGGGCGCGATCATCGTGCTGGAACTGCTGGCGCACCACTCCGGGCGACTGCTCGGCGCCGTCGTCCACGAGCCGCCGCTCATGCAGGTGCTGCCCGCGGACAGCCCGGAGCGGCAGGCCATGGAGGACATCGAACGGCTCGGCCGGGAGAAGGGTCCACTGCGCGCGTCGGCCGCGTTCGGGGCGATGACGCTCCCGGAGCCGCCGCGGATGTTCGTGTCACCGAGGGGCCAGGCGCTGATCGCCGCGACCTCCCGCGTGATGCTGGCCACCGCCGGTGCCGCGCAGCGGGTGACGGGGCGCGAGCCGGACACCATGACCCGCATCCTGGGCAACTCCCGCATCCTCGTCGAGCGGGAACTGCCCGAGTTCTGCTTCGCGTACCGGCCCGACCTCGATGCCCTGCGGGACGTGCGCGTCCCCTGGCGCCTCGCCACGGGCCGCGACAGCGAAGGGCGCCCCTACCACCGTCCCGCTCACGTCCTGAGCGAACTGCTCGGCGTAGCATGCGAGGAGTTCCCCGGAGGCCACACGGTCTACCAGCAGCTTCCGGAGGAGTTCACCCAGCGGCTGACCACGATTCTGGACCAACTCTCCTCATGA	MGKHESVREQAGVARSTTVLVSCARLHTERVGQGPALVLVPGGGGDAGMFEDVVPLLAERFTVITYDRRGNSRSPLADPAARIDVPQQADDVIAILDHYGIDQAYVFGNSGGAIIVLELLAHHSGRLLGAVVHEPPLMQVLPADSPERQAMEDIERLGREKGPLRASAAFGAMTLPEPPRMFVSPRGQALIAATSRVMLATAGAAQRVTGREPDTMTRILGNSRILVERELPEFCFAYRPDLDALRDVRVPWRLATGRDSEGRPYHRPAHVLSELLGVACEEFPGGHTVYQQLPEEFTQRLTTILDQLSS	MKKKLLWILILGLIIISCKQRKTEMKEKIIKTNGIELCTESFGNKKNPAILLVAGATVSMLYWDTEFCQQLSEKGFFVIRYDNRDVGKSTNYEPGSTPYDIVDLTNDAISILDGYKIDKAHFVGISLGGLISQIASIKFADRVNSLTLMSSGPWGDSDPTIPEMDTSILDFHSKAGTVNWTNEDSVVNYLIQGAELMSGKKQFDKQRSEKLIRAEFNRANNYISMFNHAASQGGGGEEYWNRLNEIKQPTLIIHGTDDKIWHYKNAGFLLEKIKGSNLITLEGTGHELHVDDWKSIIDGIEKHIND	101.31	gnl|BL_ORD_ID|4956|hsp_num:0	5948			48	393	tigecycline
BGC0001409.1|Dutomycin_42 # 50948 # 51601 # 1 # ID=1_42;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.697	BGC0001409.1|Dutomycin_42 	50948	51601	+	Loose	400	56.9954	tetR	24.38	3003479	protein overexpression model	n/a	n/a	tetracycline antibiotic	antibiotic target alteration; antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAGACCGACAAGGGCGGCGCGGCGGACGGACGGCCGTCCCCGCGCGTCAGACCGGCGCTGAACCGGACGTACATCGCCGCCGCCGCACTGGCCCTGATCGACGCCAACGGTCTCGGCAACTTCTCGATGCGCAAGCTCGGCGCGGGGCTCGGGGTCGACCCGATGGCGGTGTACCGCTACTTCAGGGACCAGGAGGAGCTGTTCGACGGTATCGCGGAGGCGCTCTTCGACGAGCTCGACGTCGACTCGCTGCCCTGGGAGGGCACTTGGCGCGCGGTCGCCGAGCAGTACTGCCGGCGACTGCGCGACACGCTGCTCCGGCATCCGCAGGCGGTCTCGGTCTTCGCGACCCGTCCGGTGCGCTCGCGTGCGTCGATCGACACGGGCGTACGGATCATCGAGCTGCTCCGGGCCGAGGGATTCACCCCGACCCACGCCCTGCAGATCGCCCGCTGTCTGCGCGAGTTCACCATCGGGCACGCGCTGAGCCTGGCGGTGGTGCGGCTCGGTTCGCAGAGCCGCAGCAAGAAGCCCGCGCCCGAATCGCCCGCGTACAACATCCTCGCCCGCGCGGCCGACGACACGGAGATCGACGAACACTTCGACATCGGCCTCACAGCGATGCTGGACGGCTTCGAGCGGCTGATCTGA	MKTDKGGAADGRPSPRVRPALNRTYIAAAALALIDANGLGNFSMRKLGAGLGVDPMAVYRYFRDQEELFDGIAEALFDELDVDSLPWEGTWRAVAEQYCRRLRDTLLRHPQAVSVFATRPVRSRASIDTGVRIIELLRAEGFTPTHALQIARCLREFTIGHALSLAVVRLGSQSRSKKPAPESPAYNILARAADDTEIDEHFDIGLTAMLDGFERLI	MMSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEMLDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAFLCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDHQGAEPAFLFGLELIICGLEKQLKCESGS	104.33	gnl|BL_ORD_ID|442|hsp_num:0	276			12	600	tetracycline
BGC0001409.1|Dutomycin_43 # 51654 # 52418 # -1 # ID=1_43;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=3bp;gc_cont=0.699	BGC0001409.1|Dutomycin_43 	51654	52418	-	Loose	700	27.335	tet(41)	36.36	3000569	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAATTCCGCAACTGTCAGAAACCTACTGGTGCGTGGCATGCTCGCGGGTCTCGCCGCAGGCCTGCTCGCCCTTGTCGTCGCCTACTTCCTGGGTGAGCCGCGCGTGGACTCGGCGATCGCCTACGAGGAGGCGCACTCGCACGAGCACGGCATGGAGATCGTCTCCCGCACGATGCAGTCCACCGGCGGCCTGGCCACCGGTGTCCTCGTCTACGGGGTCTCGTTCGGCGGGATCGCCGCCCTCGCGTACTGCTTCGCCCTCGGCAGGATCGGCCGCTTCGGGCCGCGCGCCAGCGCGCTCCTGCTGTCGGCGGCGGGCCTGCTCGCCGTGTACGTCGTGCCGTTCCTGAAGTACCCGGCCAACCCGCCGTCCGTCGGTGACCCCGACACCATCGGCAAGCGCACGACCCTGTACTTCCTGATGATGGTGCTCAGCGTCCTGCTCGCCGTCGCCACGGTCATCCTGGGCAAGCGCCTCGCGCCGCGCCTGGGCAACTGGAACGCGACGCTCGCGGCGGGCGCGTTCTTCGTCCTCGCCATCGGCCTCGCGTACGCGTTCCTGCCGGCCGTCAACGAGGTCCCGAAGGACTTCTCCGCCTCCCTGCTCTGGCAGTTCCGCCTCGCGGCCCTGGCCATCCAGCTGACCCTGTGGACCGCCTTCGGTCTTGTCTTCGGGGTGCTGGCGGAGCGGGTACTGGCTCCACGACCGGCCACCGTGCGGGAGCAGGAGCCCGCCGCGGAGGCAACTCCCGTCGCTCACTGA	MNSATVRNLLVRGMLAGLAAGLLALVVAYFLGEPRVDSAIAYEEAHSHEHGMEIVSRTMQSTGGLATGVLVYGVSFGGIAALAYCFALGRIGRFGPRASALLLSAAGLLAVYVVPFLKYPANPPSVGDPDTIGKRTTLYFLMMVLSVLLAVATVILGKRLAPRLGNWNATLAAGAFFVLAIGLAYAFLPAVNEVPKDFSASLLWQFRLAALAIQLTLWTAFGLVFGVLAERVLAPRPATVREQEPAAEATPVAH	MKKPMLVILLTVLLDAVGIGLIMPILPALLRSLGGLDAGSVHYGALLAAYALMQFLFSPILGALSDRFGRRPVLLISLAGAAADYLLMAFAPTLAWLYLGRLLAGITGANMAVATAYVTDITPVGQRARRFGLVGAVFGVGFIVGPLLGGSLGEWHLHAPFLAAAMMNALNLVMAFFLLPESRKSRPRAAEKIRLNPFSSLRRLHGKPGLLPLAGIYLVMALVSQAPATLWILYGQDRFGWSMMVAGLSLAGYGACHALSQAFAIGPLVARLGERKALLIGLAADAVGLALLSVATRGWAPFALLPFFAAGGMALPALQALMAHKVDDDHQGELQGTLASMGSLIGVAGPLVATALYAATRDVWPGLVWALAAALYLVVPPLLARSRARDAAP	64.63	gnl|BL_ORD_ID|1486|hsp_num:0	1584			66	261	tetracycline
BGC0001409.1|Dutomycin_44 # 52444 # 52665 # -1 # ID=1_44;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.703	BGC0001409.1|Dutomycin_44 	52444	52665	-	Loose	1000	26.1794	MCR-10.2	41.67	3007277	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGGCGCAGTCCGTCGCTCAGCCGACCGCTACCCCCACCGCCGTTCCCGCGAAGCTGCCGATCGGCGCGATCGCCCCCTGGGCGGTCTTCTTCGGCATCCTGATGCTGGTCCTGCTCTACTTCGTCGGCGCCGAACAGGGCGCCACCTCCCTCGTGTCCGGCGAGAACGTGCACGAGTGGGTGCACGACGCCCGCCACCTCCTCGGCTTCCCCTGCCACTGA	MAQSVAQPTATPTAVPAKLPIGAIAPWAVFFGILMLVLLYFVGAEQGATSLVSGENVHEWVHDARHLLGFPCH	MPVLFRMRVIPLVLLLALVFAFLLNWPVLLHFYDILSRLEHVRAGFVISIPFVLVAALNFVFMPFSVRYLLKPFFALLLVTGSVVSYATLKYKVMFDQSMIENILETNPQEAHSYLNGSLVLWLVFMGILPAILLFLIKIEYTDKWYKGVAHRLLSMLASLILIAGVAALYYQDYASVGRNNPTLNKEIIPANYAYSTFHYVKDTYFTTKMPFRTLGDDARRVTRNGKPTLMFLVIGETARSQNFSMNGYPRDTNAFTSKIDGVISFRNMRSCGTATAVSVPCMFSDMNRTDYDGKKAAGSENVLDIVQKTGVSLLWKENDGGCKGVCSRIPTVEINPGISKKLCDGKTCYDDVMLENLDTEIGKMAGDKLIAFHMIGSHGPTYYQRYPAEHRHFMPECARSDIENCTQEQLVNTYDNTIRHTDYVLAQMIEKLKQYSEQYNTVLLYVSDHGESLGESGLYLHGTPYKLAPDQQTHIPMQLWMSPDFIAAKNINAACLQHNAVNRTYSHDNLFASVLGLWDITTGAYLPESDLFRECRG	13.54	gnl|BL_ORD_ID|4705|hsp_num:0	5882			351	423	colistin A; colistin B
BGC0001409.1|Dutomycin_45 # 52774 # 52884 # 1 # ID=1_45;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.649	BGC0001409.1|Dutomycin_45 	52774	52884	+	Loose	500	23.0978	MSI-OXA	64.29	3003719	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MSI-OXA family beta-lactamase	ATGGGCTTACAGTGGCGCGACCGTGCCGGATTTCCACCGGACTTCCGCCGAACCGTCGTCAATATCGACGAGACCGTACCGCGTGGCGGGGTTCCGGCCAAGGGCGCATGA	MGLQWRDRAGFPPDFRRTVVNIDETVPRGGVPAKGA	MSHTFIIDRLGASMIKQILAALLLISPLLAQAAEWKESAQVARLFKQEGVSGTFVVYDVAADSYTVHDRQRANTRFIPASTFKIPNTLIALAHGAVANVDEVVPYGGKPVARPEWARDMGLREAIRISNVPVYQEVARRVGLDRMRSELVRMKYGNMQTGTVVDRFWLDGPLKISAVEQTEFLTKLAQGTLPFTNVAMAAVREISRQDGAPELYAKTGWGSRPGEADIGWWVGWLKKDGKLYAFALNMDLPDGAQDKRVSLAKAALRELGLL	13.24	gnl|BL_ORD_ID|2031|hsp_num:0	2234			285	327	
BGC0001409.1|Dutomycin_46 # 52856 # 53293 # 1 # ID=1_46;partial=01;start_type=GTG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.740	BGC0001409.1|Dutomycin_46 	52856	53293	+	Loose	1900	29.6462	MexI	28.57	3000808	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGCGGGGTTCCGGCCAAGGGCGCATGAGGCGCACGGCGTGCGCCCCTTGCCCGGTCACCTGGCCGGTTCCCTTACCGCACAAGGGTTTTACACAGGAAAGTGGATGTGGATGACGAGCCGAGTGATCCTGATCTCAGCCGCGATCAGCGAGGCACTGCGCGAGGCCCGCTTCGACGACGGATGTCCGGTCGACGCCGCGGGGCTGCGGCTCGCGCGGGCGGCCGCGGGCGCGGTTCCGGCCGCGGCCCTGCTGTGGGTCTCCCCCACCGTGCGGTGCCGGGAGACCGCGGGCGCGCTCGGCCTCGACACCCCTGCGGACGCACCGGAGTTGGCCGGTCTGGACGTGGGCCGCTGGCGTGGGACGACCCTCGACGAGGTGAGCGCGAAGGAGCCGGAGGCGGTGGCGCGGTGGCTGGCCGATCCCGGATCCGCGCCG	MAGFRPRAHEAHGVRPLPGHLAGSLTAQGFYTGKWMWMTSRVILISAAISEALREARFDDGCPVDAAGLRLARAAAGAVPAAALLWVSPTVRCRETAGALGLDTPADAPELAGLDVGRWRGTTLDEVSAKEPEAVARWLADPGSAP	MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQGFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLPERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQRLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDFREMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIRKLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLIPVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPVAAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTLSPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPLLYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTDGPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMVLRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDIGESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVRVALQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQYTQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIYTQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGLVPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLAEADLLVNKA	14.19	gnl|BL_ORD_ID|4683|hsp_num:0	1647			1617	1806	acriflavine; tetracycline; norfloxacin
BGC0001409.1|Dutomycin_22 # 21221 # 22531 # -1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.709	BGC0001409.1|Dutomycin_22 	21221	22531	-	Loose	750	189.504	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	35.29	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGGAAAGCCGGATCCACTTCAGATATCGGGGGATGAACAGGATGGCCCGAGACGTAGTGATAACGGGTGTCGGCGTGGTCGCTCCAGGCGGAATCGGCAGCAAACCGTTCTGGGACCTGCTGGTCTCCGGCCGCACCGCGACCCGTACCATCACCCATTTCGACGCCGCGCCCTTTCGTTCGACCGTGGCCGCCGAGTGCGACTTCGACGCGGAGGCGGAAGGCCTCACGACCGAGGAGGCCGGCCGGCTCGACCGGGCCACCCAGTTCGCGCTGGTGGCGACCCGCGAAGCGGTGGGCGACAGCGGCCTCGAAACCGGGGAACTCGACCGTTACCGCACAGGCGTCACCATCGGCAGCGCCGTCGGCTGCACCACCAGCCTGGAACGCGAGTACGTCGTCGCCAGCCACGGCGGCCGCGACTGGCTCGTGGACCCGGACCTCGCGGTCCCGCACCTCTACGACTACTTCGTGCCGAGCTCGATGGCCGCCGAGGTGGCCTGGGCCGTCGGCGCGCAGGGCCCGTGCTCCGTGGTCTCCACGGGCTGTACCTCCGGGCTCGACGCCGTCGGCCACGCCGTACGGCTCATCGAGGAGGGCTCGGCCGACGTCATGATCGCGGGCGGCACCGACGCCCCCATCTCGCCCATCACCGTCGCCTGCTTCGACGCGATCAGGGCGACCACGCCCCGCAACGACGAACCGGCCACCGCCTCCCGCCCGTTCGACCGCAGCCGCAACGGCTTCGTGCTCGGCGAGGGCTGCGCGGTCTTCGTCCTGGAGGAGCGGGAGCGGGCACGGGCCCGCGGCGCCCATGTGTACGCGGGCGTCGGCGGGTTCGCCTCACGGTGCAACGCCTTCCACATGACGGGGCTGCGCCCGGACGGCAAGGAGATGGCCGCCGCCATCGAGACGGCCCTCGTGGAGGCCCGGGTGACGGCGGACGAGGTGAGCTACATCAACGCGCACGGCTCCGGCACCAAGCAGAACGACCGGCACGAGACCGCCGCGTTCAAGAAGGCGCTGGGCGACCACGCCCGCCGTACGCCCGTCAGCTCCATCAAGTCGATGATCGGCCATTCGCTCGGCGCGATCGGCTCCGTCGAACTCGCGGCCTGCGCGCTCGCCATCGAGAACGGCGCGGTTCCCCCGACGGCCAATCTGCACGAGCCGGACCCGGAATGCGACCTGGACTATGTGCCGTTGACCGCCCGGGAGGCGCGGCTCGACGTCGTCCTCAGCGTCGGCAGCGGATTCGGCGGTTTCCAGAGCGCGATGGTGCTCACCCGGCCCGGTCGGGCGGAACGGTGA	MESRIHFRYRGMNRMARDVVITGVGVVAPGGIGSKPFWDLLVSGRTATRTITHFDAAPFRSTVAAECDFDAEAEGLTTEEAGRLDRATQFALVATREAVGDSGLETGELDRYRTGVTIGSAVGCTTSLEREYVVASHGGRDWLVDPDLAVPHLYDYFVPSSMAAEVAWAVGAQGPCSVVSTGCTSGLDAVGHAVRLIEEGSADVMIAGGTDAPISPITVACFDAIRATTPRNDEPATASRPFDRSRNGFVLGEGCAVFVLEERERARARGAHVYAGVGGFASRCNAFHMTGLRPDGKEMAAAIETALVEARVTADEVSYINAHGSGTKQNDRHETAAFKKALGDHARRTPVSSIKSMIGHSLGAIGSVELAACALAIENGAVPPTANLHEPDPECDLDYVPLTAREARLDVVLSVGSGFGGFQSAMVLTRPGRAER	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	104.81	gnl|BL_ORD_ID|1968|hsp_num:0	1943			303	1245	isoniazid
